{"gene":"KITLG","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":1990,"finding":"KITLG (stem cell factor/SCF) was cloned from rat and human; truncated recombinant forms expressed in E. coli and mammalian cells retained biological activity, augmenting proliferation of myeloid and lymphoid hematopoietic progenitors in bone marrow cultures and showing synergy with colony-stimulating factors.","method":"cDNA cloning, recombinant protein expression, hematopoietic progenitor proliferation assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — original cloning with functional in vitro validation, foundational paper","pmids":["2208279"],"is_preprint":false},{"year":1992,"finding":"KITLG is produced as two transmembrane isoforms (KL-1 and KL-2) generated by alternative splicing. KL-1 is efficiently cleaved at the cell surface to produce soluble KL; KL-2 lacks the major proteolytic cleavage site (removed by splicing) and is shed with reduced efficiency. Phorbol ester and calcium ionophore induce cleavage of both isoforms at similar rates, indicating regulated shedding. The relative abundance of KL-1 vs KL-2 is controlled in a tissue-specific manner.","method":"Alternative splicing analysis, phorbol ester/calcium ionophore treatment, Western blot, cell surface cleavage assays","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal biochemical methods, replicated across isoforms","pmids":["1378327"],"is_preprint":false},{"year":2002,"finding":"Gab2, an adaptor molecule with a pleckstrin homology domain, is required for KitL/c-Kit signaling and mast cell development. In Gab2-deficient mice, mast cell numbers were markedly reduced, and bone marrow-derived mast cells grew poorly in response to KitL. KitL-induced ERK MAP kinase and Akt activation were impaired in Gab2-deficient cells, placing Gab2 downstream of KitL/c-Kit and upstream of ERK and PI3K/Akt pathways.","method":"Gab2 knockout mouse, bone marrow-derived mast cell cultures, kinase activation assays (ERK, Akt Western blot)","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular and biochemical phenotype, multiple downstream readouts","pmids":["11861309"],"is_preprint":false},{"year":2004,"finding":"A C-terminal valine residue in the cytoplasmic tail of Kitl (positioned 19–36 amino acids from the transmembrane/cytoplasmic domain border) acts as a specific ER export signal. Deletion or substitution of this valine causes ER accumulation of Kitl and reduced cell surface transport. The valine-dependent motif recruits Kitl into COPII-coated ER exit sites for vesicular ER-to-Golgi transport.","method":"Mutagenesis, live-cell imaging with GFP fusion and ts-VSV-G reporter, subcellular fractionation, fluorescence microscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — mutagenesis combined with live imaging and functional localization, mechanistically rigorous","pmids":["15475566"],"is_preprint":false},{"year":2004,"finding":"SCF/c-Kit signaling promotes survival, migration, and capillary tube formation of human umbilical vein endothelial cells by rapidly activating Akt, Erk1/2, and c-Kit tyrosine phosphorylation. PI3K inhibitors (wortmannin, LY294002) and MEK inhibitor (PD98059) abrogated survival and tube formation, and c-Kit inhibitor STI-571 blocked these effects, demonstrating that the SCF/c-Kit → PI3K/Akt and Erk1/2 axes mediate endothelial cell survival and morphogenesis.","method":"Pharmacological inhibitors, c-Kit phosphorylation assays, cell survival/migration/tube formation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple inhibitors and orthogonal functional assays with defined pathway placement","pmids":["14985355"],"is_preprint":false},{"year":2004,"finding":"c-Kit activation by SCF in mast cells uniquely activates STAT5 and STAT6 phosphorylation, while FcεRI uniquely activates PKC-dependent c-Jun/AP-1 induction. Both receptors converge on PI3K/Akt and MAPK. Kit ligand failed to induce degranulation alone but strongly synergized with antigen, and continuous KL exposure down-regulated signals that were reactivated by antigen co-stimulation.","method":"Phospho-specific Western blotting, cytokine transcript quantification, degranulation assays in human mast cells from CD34+ progenitors","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple signaling readouts in primary human cells with pharmacological and genetic dissection","pmids":["15217825"],"is_preprint":false},{"year":2005,"finding":"Analysis of an allelic series of hypomorphic KitlSl mutations in mice revealed that KITL requirements differ during PGC development: proliferation before and after migration requires different levels of KITL function, and different threshold levels of KITL support proliferation versus migration of primordial germ cells.","method":"ENU-induced hypomorphic allele series, genetic comparison of PGC numbers at developmental stages, histology","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 — multiple alleles with graded phenotypes enabling dissection of function, but no direct biochemical mechanistic assay","pmids":["15917341"],"is_preprint":false},{"year":2006,"finding":"KIT is activated in all GISTs examined, even without KIT mutations. Both membrane-bound and soluble SCF mRNA isoforms are co-expressed in GIST cells and primary cultures, and SCF protein is detected within GIST cells, suggesting an autocrine/paracrine mechanism of KIT activation by KITLG.","method":"RT-PCR, ELISA, immunohistochemistry, Western blotting for phospho-KIT, primary GIST cell cultures","journal":"British journal of cancer","confidence":"Medium","confidence_rationale":"Tier 3 — co-expression and protein detection without genetic perturbation of the loop","pmids":["16570044"],"is_preprint":false},{"year":2007,"finding":"Crystal structures of the entire KIT ectodomain before and after SCF stimulation showed that SCF binding drives KIT dimerization, with SCF's sole role being to bring two KIT molecules into proximity. Receptor dimerization induces conformational changes enabling lateral interactions between membrane-proximal Ig-like domains D4 and D5 of two KIT molecules. Point mutations in D4-D4 contact residues compromised KIT activation in cultured cells, and oncogenic mutations map to the D5-D5 interface.","method":"X-ray crystallography, site-directed mutagenesis, cell-based KIT activation assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with mutagenesis validation in cells, highly cited foundational structural paper","pmids":["17662946"],"is_preprint":false},{"year":2007,"finding":"cis-regulatory changes in the Kitlg gene underlie parallel evolution of reduced pigmentation in sticklebacks and contribute to human skin color variation. A divergent regulatory allele of Kitlg reduces expression in gill and skin tissue in freshwater sticklebacks, and admixture mapping confirmed the KITLG genomic region affects human skin color. The regulatory changes rather than coding changes drive pigmentation differences.","method":"Genetic crosses, high-resolution mapping, expression studies, admixture mapping in humans","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — genetic mapping combined with expression and functional evidence across species","pmids":["18083106"],"is_preprint":false},{"year":2007,"finding":"SCF (KITLG) overexpressed by neurons following brain injury and by glioma cells directly activates brain microvascular endothelial cells in vitro and induces angiogenesis in vivo. SCF downregulation inhibited tumor-mediated angiogenesis and glioma growth in vivo.","method":"In vitro endothelial cell activation assays, in vivo glioma xenograft models with SCF downregulation (shRNA), immunohistochemistry","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function in vivo with defined angiogenic phenotype","pmids":["16616334"],"is_preprint":false},{"year":2008,"finding":"VCD-induced ovarian follicle loss is associated with decreased Kit mRNA/protein and increased Kitl mRNA/protein expression. Addition of exogenous KITL to ovarian cultures during VCD exposure attenuated follicle loss, supporting that KIT/KITL signaling is critical for primordial and primary follicle survival and that VCD compromises this pathway.","method":"Microarray, RT-PCR, Western blot, in vitro ovarian culture with growth factor rescue experiments","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2–3 — rescue experiment provides functional evidence but mechanism is inferred","pmids":["18448842"],"is_preprint":false},{"year":2009,"finding":"SCF inhibits IGF-I-mediated proliferation of growth plate chondrocytes by attenuating ERK1/2 activation, and promotes chondrocyte differentiation in ATDC5 cells with distinct expression patterns for collagen X, collagen 2, aggrecan, and lysyl oxidase.","method":"Isolated bovine chondrocyte proliferation assays, ATDC5 differentiation assays, ERK1/2 phosphorylation Western blots","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — direct cell-based assays with defined signaling readout, but single laboratory","pmids":["19897599"],"is_preprint":false},{"year":2011,"finding":"TAK1 directly regulates SCF (KITLG) expression, which activates the PKBα (Akt) pro-survival pathway in keratinocytes to protect them from ROS-mediated apoptosis. TAK1 deficiency led to increased apoptosis and elevated ROS. Ectopic TAK1 expression or exogenous SCF restored this phenotype, and inhibition of SCF/c-Kit/PKBα pathway increased ROS and apoptosis in normal keratinocytes.","method":"TAK1 knockdown/overexpression, recombinant SCF rescue, pharmacological inhibitors of c-Kit/PKBα, FACS for ROS and apoptosis, organotypic skin culture","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 — multiple complementary approaches with gain- and loss-of-function and rescue, defining pathway placement","pmids":["21233843"],"is_preprint":false},{"year":2011,"finding":"KITLG mutations cause familial progressive hyper- and hypopigmentation (FPHH): three mutations identified in conserved β-strand of KITLG. In vitro studies showed the p.His67_Cys68delinsArg transmembrane isoform is undetectable at the cell membrane, while p.Leu104Val is membrane-located but reduces soluble KITLG secretion. These data suggest NS-UHL/AHL mutations cause loss-of-function, while the WS2 mutation may act via dominant-negative or gain-of-function through altered membrane incorporation and reduced secretion.","method":"Whole-exome sequencing, linkage analysis, in vitro cell membrane localization assays, secretion assays","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro functional studies of specific mutations with defined localization and secretion readouts","pmids":["21368769","26522471"],"is_preprint":false},{"year":2014,"finding":"A molecular basis for blond hair color in northern Europeans was identified: a regulatory enhancer within the KITLG locus contains the SNP rs12821256 that alters a LEF1 (lymphoid enhancer-binding factor 1) transcription factor binding site, reducing LEF1 responsiveness and enhancer activity in keratinocytes. Mice carrying the derived human KITLG enhancer variant show significantly reduced hair pigmentation, confirming that cis-regulatory reduction of KITLG expression drives the blond hair phenotype.","method":"Functional enhancer assays in keratinocytes, LEF1 binding site mutagenesis, transgenic mouse enhancer knock-in experiments","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1–2 — enhancer assays, mutagenesis of transcription factor binding site, and in vivo mouse confirmation","pmids":["24880339"],"is_preprint":false},{"year":2015,"finding":"KITLG is a direct target of miR-34c in colorectal cancer cells. Resveratrol upregulates miR-34c (via promoter demethylation), which knocks down KITLG and suppresses CRC cell viability, proliferation, migration, invasion and promotes apoptosis. The effect was enhanced in p53-positive cells and likely involves PI3K/Akt pathway inactivation. In vivo, resveratrol elevated miR-34c and reduced KITLG in xenografts.","method":"Luciferase reporter assay (miR-34c targeting KITLG 3'UTR), lentiviral miR-34c overexpression/inhibition, MSP for methylation, xenograft models","journal":"BMC cancer","confidence":"Medium","confidence_rationale":"Tier 2 — direct miRNA-target validation by luciferase reporter with in vivo confirmation, but pathway placement is partially inferred","pmids":["26674205"],"is_preprint":false},{"year":2015,"finding":"KITLG mRNA is expressed as two isoforms (KITL1 and KITL2) in the adult human ovary, with both KITL protein isoforms present in granulosa cells and ovarian cortex. c-Kit and KITL proteins are expressed in multiple follicle cell types (granulosa, theca, stromal) throughout folliculogenesis, and oocytes express c-kit exclusively. Unlike animal models, expression of both proteins is less cell-type specific in humans, suggesting autocrine signaling occurs within the human ovary.","method":"RT-PCR for isoform detection, Western blot, immunohistochemistry in human ovarian tissue","journal":"Journal of ovarian research","confidence":"Medium","confidence_rationale":"Tier 3 — descriptive localization in human tissue without functional perturbation","pmids":["26008799"],"is_preprint":false},{"year":2017,"finding":"MAPK3/1 (ERK1/2) participates in primordial follicle activation through the mTORC1-KITL signaling pathway in pre-granulosa cells. MAPK3/1 inhibitor U0126 reduced follicle activation, decreased phosphorylation of TSC2, S6K1, rpS6, and reduced KITL expression. U0126 also decreased Akt phosphorylation and blocked Foxo3 nuclear export in oocytes, placing MAPK3/1 upstream of mTORC1-KITL in granulosa cells and KIT-PI3K signaling in oocytes.","method":"Ex vivo ovarian culture with MAPK3/1 inhibitor, Western blot for mTORC1 components, KITL expression analysis, PTEN inhibitor co-experiments, immunofluorescence for Foxo3 localization","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological dissection with multiple pathway readouts, but reliance on inhibitors","pmids":["28218391"],"is_preprint":false},{"year":2017,"finding":"Bone marrow adipocytes synthesize SCF (KITLG) and promote HSC maintenance and haematopoietic regeneration after irradiation or chemotherapy. Adipocyte-specific Scf deletion (using Adipoq-Cre/ER) inhibited haematopoietic regeneration, depleted HSCs (in tail vertebrae with abundant adipocytes), and reduced mouse survival after irradiation. SCF from LepR+ stromal cells also promoted regeneration.","method":"Conditional knockout (Adipoq-Cre/ER-driven Scf deletion), irradiation/5-FU models, HSC frequency measurement, survival curves","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 — clean conditional KO with defined cellular phenotype (HSC depletion, reduced survival), replicated with LepR+ deletion","pmids":["28714970"],"is_preprint":false},{"year":2019,"finding":"SCF/cKIT signaling induces pathological ocular neovascularization through phosphorylation of glycogen synthase kinase-3β (GSK-3β) and enhancement of nuclear translocation of β-catenin and transcription of β-catenin target genes. Hypoxia upregulates cKIT in endothelial cells, enhancing the angiogenic response to SCF. Blockade of cKIT or SCF (using cKit mutant mice and anti-SCF IgG) suppressed pathological neovascularization in murine models.","method":"Hypoxia cell culture, cKit mutant mice, anti-SCF neutralizing antibody, β-catenin chemical inhibitors, in vivo retinopathy/choroidal neovascularization models, GSK-3β and β-catenin phosphorylation assays","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic and pharmacological loss-of-function with defined signaling mechanism","pmids":["31434494"],"is_preprint":false},{"year":2019,"finding":"SCF/c-Kit-activated signaling and angiogenesis require Gαi1 and Gαi3 proteins. In endothelial cells, Gαi1/3 associates with SCF-activated c-Kit, promotes c-Kit endocytosis, and facilitates binding of key adaptor proteins, thereby transducing downstream Akt-mTOR and ERK activation. Gαi1/3 silencing or KO attenuated SCF-induced HUVEC proliferation, migration, and tube formation in vitro and retinal angiogenesis in vivo. SCF/c-Kit expression was elevated in diabetic retinopathy, and SCF silencing inhibited pathological retinal angiogenesis.","method":"siRNA/shRNA knockdown, CRISPR KO, dominant-negative overexpression, endothelial-specific AAV shRNA in vivo, co-immunoprecipitation, signaling assays","journal":"International journal of biological sciences","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal loss-of-function approaches in vitro and in vivo with defined mechanistic pathway","pmids":["37063428"],"is_preprint":false},{"year":2002,"finding":"ENU-induced Kitl allelic series identified seven point mutations; five missense mutations affect residues within or near conserved alpha-helical domains of Kitl, establishing structural requirements for function. One allele causes a nonsense mutation with exon skipping, and one affects a splice site.","method":"ENU mutagenesis screen, sequencing of allelic series, structural mapping","journal":"Genetics","confidence":"Medium","confidence_rationale":"Tier 2 — allelic series establishing structure-function relationship in vivo","pmids":["12242244"],"is_preprint":false},{"year":1997,"finding":"PI3K p110delta is recruited to activated signaling complexes in leukocytes after treatment with stem cell factor (KITLG), together with p110alpha. Both associate with p85 adaptor subunits. Unlike p110alpha, p110delta does not phosphorylate p85 but harbors intrinsic autophosphorylation capacity, suggesting divergent regulatory capacities downstream of SCF/KIT.","method":"Immunoprecipitation, in vitro kinase assays, cytokine stimulation (SCF, IL-3, IL-4)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical recruitment assay with multiple cytokines; PI3K isoform characterization downstream of SCF/KIT","pmids":["9113989"],"is_preprint":false},{"year":2015,"finding":"NRG1 and KITL (SCF) activate alternative pathways downstream of retinoic acid signaling in rat spermatogonia to support pre-meiotic spermatogonial differentiation without somatic cells. KITL prevents ERBB3-deficient spermatogonial degeneration upon differentiation. ERBB2 inhibitors blocked NRG1-dependent but not KITL-dependent spermatogonial development, demonstrating that KITL uses a distinct pathway from NRG1/ERBB2.","method":"Serum/somatic cell-free spermatogonial culture, ERBB2 pharmacological inhibitors, ERBB3-deficient spermatogonia, retinoic acid stimulation","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological and genetic dissection in defined culture system establishing distinct signaling pathway","pmids":["26500786"],"is_preprint":false},{"year":2019,"finding":"miR-27a directly targets and negatively regulates KITLG expression in Cashmere goat melanocytes. Luciferase reporter assays confirmed miR-27a binding to the KITLG 3'UTR. KITLG mRNA and protein were downregulated by miR-27a overexpression in vitro and in white goat skin (which has higher miR-27a expression), demonstrating a miR-27a → KITLG regulatory axis in pigmentation.","method":"Dual-luciferase reporter assay, miR-27a overexpression, qRT-PCR and Western blot, comparison of white vs brown skin","journal":"Animal biotechnology","confidence":"Medium","confidence_rationale":"Tier 2 — direct target validation by luciferase assay with in vivo correlation","pmids":["31613171"],"is_preprint":false}],"current_model":"KITLG (KIT ligand/stem cell factor) is a transmembrane growth factor processed from two alternatively spliced isoforms (KL-1/KL-2) through regulated cell-surface proteolysis; its cytoplasmic tail contains a C-terminal valine-dependent ER export signal required for efficient cell surface delivery; it activates its receptor KIT by inducing receptor dimerization via D4-D4 lateral interactions (resolved by crystal structure), triggering downstream PI3K/Akt, ERK/MAPK, STAT5/6, and β-catenin signaling cascades that mediate survival, proliferation, migration, and angiogenesis in hematopoietic, melanocyte, germ cell, mast cell, and endothelial cell lineages; upstream, MAPK3/1 and TAK1 regulate KITLG expression to modulate these pathways, while miR-34c and miR-27a post-transcriptionally suppress KITLG; regulatory cis-elements controlling KITLG transcription (including a LEF1-responsive enhancer) drive natural variation in pigmentation across vertebrates."},"narrative":{"teleology":[{"year":1990,"claim":"Cloning of KITLG established it as a hematopoietic growth factor that synergizes with colony-stimulating factors to expand myeloid and lymphoid progenitors, defining its primary biological role.","evidence":"cDNA cloning from rat and human with recombinant protein expression and bone marrow progenitor proliferation assays","pmids":["2208279"],"confidence":"High","gaps":["receptor identity (KIT) known but structural basis of interaction unresolved","in vivo requirement not yet demonstrated by genetic loss-of-function of KITLG itself"]},{"year":1992,"claim":"Discovery of two alternatively spliced KITLG isoforms (KL-1/KL-2) with differential proteolytic shedding efficiency revealed that the balance of membrane-bound versus soluble ligand is regulated at the level of splicing and cell-surface cleavage.","evidence":"Alternative splicing analysis, phorbol ester and calcium ionophore stimulation, Western blot of shed products","pmids":["1378327"],"confidence":"High","gaps":["identity of the protease(s) responsible for constitutive and regulated shedding not determined","functional consequence of membrane-bound vs soluble forms on KIT signaling duration not dissected"]},{"year":1997,"claim":"Identification of PI3K p110δ and p110α recruitment to KIT-associated complexes after SCF stimulation placed PI3K activation as a proximal signaling event downstream of KITLG/KIT.","evidence":"Immunoprecipitation and in vitro kinase assays in leukocytes stimulated with SCF","pmids":["9113989"],"confidence":"Medium","gaps":["relative functional contributions of p110α vs p110δ downstream of KIT not determined","recruitment mechanism (direct vs adaptor-mediated) not fully resolved"]},{"year":2002,"claim":"Gab2 was identified as a required adaptor downstream of KIT, linking KITLG signaling to ERK and PI3K/Akt activation and mast cell development, thereby defining the signal transduction architecture from receptor to effector kinases.","evidence":"Gab2 knockout mice with impaired mast cell development and reduced ERK/Akt activation upon SCF stimulation","pmids":["11861309"],"confidence":"High","gaps":["whether Gab2 is required in non-mast cell lineages (e.g. melanocytes, HSCs) for KITLG signaling not tested","structural basis of Gab2–KIT interaction not resolved"]},{"year":2002,"claim":"An ENU-induced allelic series of Kitl mutations mapped functional requirements to conserved α-helical domains, establishing structure–function relationships in vivo.","evidence":"ENU mutagenesis screen with sequencing and structural mapping of seven point mutations","pmids":["12242244"],"confidence":"Medium","gaps":["no crystal structure of KITLG alone or in complex at this point to place mutations structurally","allele severity not quantitatively correlated with receptor binding affinity"]},{"year":2004,"claim":"Identification of a C-terminal valine as an ER export signal for KITLG revealed that its surface delivery depends on COPII-mediated vesicular transport, establishing a trafficking control point upstream of ligand presentation.","evidence":"Mutagenesis of cytoplasmic tail valine, live-cell GFP imaging, ER accumulation phenotype","pmids":["15475566"],"confidence":"High","gaps":["COPII coat subunit specificity for KITLG recognition not identified","whether this export signal is regulated in physiological contexts unknown"]},{"year":2004,"claim":"Demonstration that SCF/KIT activates PI3K/Akt and ERK in endothelial cells to drive survival, migration, and tube formation extended the biological scope of KITLG signaling beyond hematopoietic lineages to angiogenesis.","evidence":"Pharmacological inhibition (PI3K, MEK, c-Kit) combined with HUVEC survival, migration, and tube formation assays","pmids":["14985355"],"confidence":"High","gaps":["relative importance of soluble vs membrane-bound KITLG for angiogenesis not addressed","in vivo confirmation of endothelial-autonomous KIT requirement pending"]},{"year":2004,"claim":"SCF/KIT uniquely activates STAT5 and STAT6 in mast cells (distinct from FcεRI), revealing receptor-specific signaling that explains the non-redundant role of KITLG in mast cell biology.","evidence":"Phospho-specific Western blotting in primary human mast cells comparing SCF vs antigen stimulation","pmids":["15217825"],"confidence":"High","gaps":["direct transcriptional targets of STAT5/6 downstream of KIT in mast cells not catalogued","mechanism of synergy between SCF and antigen for degranulation not molecularly defined"]},{"year":2005,"claim":"Graded Kitl hypomorphic alleles in mice showed that different threshold levels of KITLG are required for PGC proliferation versus migration, demonstrating quantitative dose-dependence of KITLG in germ cell development.","evidence":"Phenotypic comparison of ENU-induced Kitl allelic series at multiple developmental stages","pmids":["15917341"],"confidence":"Medium","gaps":["downstream pathways mediating proliferation vs migration distinction not identified","whether membrane-bound vs soluble KITLG accounts for the threshold difference untested"]},{"year":2007,"claim":"Crystal structures of the full KIT ectodomain in complex with SCF resolved the activation mechanism: SCF induces KIT dimerization, which enables homotypic D4–D4 and D5–D5 lateral contacts essential for kinase activation, explaining how oncogenic mutations in these interfaces constitutively activate KIT.","evidence":"X-ray crystallography of KIT ectodomain ± SCF, point mutagenesis of D4–D4 contacts with cell-based KIT activation assays","pmids":["17662946"],"confidence":"High","gaps":["full-length KIT structural model including kinase domain not available","dynamics of dimer rearrangement at the membrane not captured by crystal structure"]},{"year":2007,"claim":"Cis-regulatory changes at the KITLG locus were shown to drive parallel evolution of reduced pigmentation in sticklebacks and to contribute to human skin color, establishing KITLG as a major evolutionary pigmentation gene controlled at the transcriptional level.","evidence":"Genetic crosses and expression studies in sticklebacks combined with admixture mapping in humans","pmids":["18083106"],"confidence":"High","gaps":["specific transcription factors and enhancer elements not yet identified","quantitative effect size in human pigmentation not precisely measured"]},{"year":2011,"claim":"TAK1 was placed upstream of KITLG expression in keratinocytes, linking innate signaling kinases to SCF/c-Kit/Akt-mediated protection against ROS-induced apoptosis and defining a TAK1→KITLG→KIT→Akt survival axis in skin.","evidence":"TAK1 knockdown/overexpression, exogenous SCF rescue, pharmacological KIT/Akt inhibition, organotypic skin culture","pmids":["21233843"],"confidence":"High","gaps":["mechanism by which TAK1 induces KITLG transcription not defined","whether this axis operates in non-keratinocyte contexts untested"]},{"year":2011,"claim":"Identification of KITLG coding mutations in familial progressive hyper- and hypopigmentation (FPHH) established KITLG as a Mendelian pigmentation disease gene and demonstrated that specific mutations impair membrane localization or soluble ligand secretion.","evidence":"Whole-exome sequencing with linkage analysis, in vitro membrane localization and secretion assays for identified mutations","pmids":["21368769","26522471"],"confidence":"Medium","gaps":["dominant-negative vs haploinsufficiency mechanism for specific alleles not fully resolved","effect of mutations on KIT binding affinity not measured"]},{"year":2014,"claim":"A specific SNP (rs12821256) in a KITLG enhancer was shown to reduce LEF1-dependent transcription, and transgenic mice carrying the human variant had reduced hair pigmentation, providing the molecular basis for blond hair in Europeans.","evidence":"Enhancer reporter assays, LEF1 binding site mutagenesis, transgenic mouse enhancer knock-in","pmids":["24880339"],"confidence":"High","gaps":["whether additional transcription factors cooperate with LEF1 at this enhancer unknown","melanocyte-specific vs keratinocyte-specific enhancer activity not fully dissected"]},{"year":2015,"claim":"KITLG was validated as a direct post-transcriptional target of miR-34c and miR-27a, establishing microRNA-mediated regulation of KITLG expression in colorectal cancer and melanocyte pigmentation contexts.","evidence":"Dual-luciferase 3′UTR reporter assays confirming direct miRNA binding, miRNA overexpression/inhibition with KITLG protein readouts","pmids":["26674205","31613171"],"confidence":"Medium","gaps":["physiological relevance of miR-34c regulation of KITLG in normal colon epithelium not established","combinatorial effects of multiple KITLG-targeting miRNAs not assessed"]},{"year":2017,"claim":"Conditional deletion of Scf in bone marrow adipocytes demonstrated that adipocyte-derived KITLG is required for HSC maintenance and hematopoietic regeneration after myeloablation, identifying a niche-specific source of KITLG critical for emergency hematopoiesis.","evidence":"Adipoq-Cre/ER-driven conditional Scf knockout, irradiation and 5-FU models, HSC enumeration, survival analysis","pmids":["28714970"],"confidence":"High","gaps":["whether adipocyte-derived KITLG acts via soluble or membrane-bound isoform in the niche not determined","relative contributions of adipocyte vs LepR+ stromal KITLG not quantitatively resolved"]},{"year":2019,"claim":"The SCF/KIT→GSK-3β→β-catenin signaling axis was identified as a driver of pathological neovascularization, and Gαi1/3 proteins were shown to be required co-transducers for KIT-mediated Akt-mTOR and ERK activation in endothelial cells, completing the proximal signaling chain from receptor to effectors.","evidence":"cKit mutant mice, anti-SCF antibody, β-catenin inhibitors in retinopathy models; Gαi1/3 CRISPR KO and co-immunoprecipitation with activated KIT in HUVECs","pmids":["31434494","37063428"],"confidence":"High","gaps":["mechanism by which Gαi1/3 couples to a receptor tyrosine kinase (rather than GPCR) is structurally undefined","whether Gαi1/3 requirement extends to non-endothelial KITLG-responsive lineages is unknown"]},{"year":null,"claim":"The identity of the protease(s) responsible for constitutive and regulated KITLG ectodomain shedding, the structural basis for isoform-specific cleavage, and how membrane-bound versus soluble KITLG differentially activate KIT signaling duration and quality remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["sheddase identity not definitively assigned despite candidates (ADAM17/ADAM10)","no quantitative model of how soluble vs membrane-bound SCF ratio tunes signal output in vivo","full-length KIT–SCF complex structure including transmembrane and kinase domains unavailable"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,4,8,10,19,20,21]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,3,14]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[1,14]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,4,5,8,13,20,21,23]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,9,15,24]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,2,19]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[13,16]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[7,16,20]}],"complexes":[],"partners":["KIT","GAB2","GNAI1","GNAI3","PIK3CD","LEF1"],"other_free_text":[]},"mechanistic_narrative":"KITLG (Kit ligand/stem cell factor) is a transmembrane growth factor that signals through the receptor tyrosine kinase KIT to regulate survival, proliferation, migration, and differentiation of hematopoietic stem cells, melanocytes, germ cells, mast cells, and endothelial cells [PMID:2208279, PMID:11861309, PMID:28714970]. It is produced as two alternatively spliced transmembrane isoforms (KL-1 and KL-2) that differ in susceptibility to regulated proteolytic shedding, with tissue-specific isoform ratios controlling the balance of membrane-bound versus soluble ligand [PMID:1378327]; efficient surface delivery requires a C-terminal valine-dependent ER export signal in its cytoplasmic tail [PMID:15475566]. Binding of KITLG induces KIT receptor dimerization via lateral D4–D4 and D5–D5 domain contacts, activating downstream PI3K/Akt, ERK/MAPK, STAT5/6, and GSK-3β/β-catenin cascades through adaptors including Gab2 and Gαi1/3 [PMID:17662946, PMID:11861309, PMID:15217825, PMID:31434494, PMID:37063428]. Cis-regulatory variation at the KITLG locus—including a LEF1-responsive enhancer harboring the SNP rs12821256—underlies natural pigmentation differences across vertebrates, and coding mutations in KITLG cause familial progressive hyper- and hypopigmentation [PMID:24880339, PMID:18083106, PMID:21368769]."},"prefetch_data":{"uniprot":{"accession":"P21583","full_name":"Kit ligand","aliases":["Mast cell growth factor","MGF","Stem cell factor","SCF","c-Kit ligand"],"length_aa":273,"mass_kda":30.9,"function":"Ligand for the receptor-type protein-tyrosine kinase KIT. Plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. KITLG/SCF binding can activate several signaling pathways. Promotes phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and subsequent activation of the kinase AKT1. KITLG/SCF and KIT also transmit signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. KITLG/SCF and KIT promote activation of STAT family members STAT1, STAT3 and STAT5. KITLG/SCF and KIT promote activation of PLCG1, leading to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KITLG/SCF acts synergistically with other cytokines, probably interleukins","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P21583/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KITLG","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KITLG","total_profiled":1310},"omim":[{"mim_id":"621205","title":"MICRO RNA 129-2; MIR129-2","url":"https://www.omim.org/entry/621205"},{"mim_id":"621204","title":"MICRO RNA 129-1; MIR129-1","url":"https://www.omim.org/entry/621204"},{"mim_id":"619947","title":"WAARDENBURG SYNDROME, TYPE 2F; WS2F","url":"https://www.omim.org/entry/619947"},{"mim_id":"616697","title":"DEAFNESS, AUTOSOMAL DOMINANT 69; DFNA69","url":"https://www.omim.org/entry/616697"},{"mim_id":"612839","title":"TET METHYLCYTOSINE DIOXYGENASE 2; TET2","url":"https://www.omim.org/entry/612839"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/KITLG"},"hgnc":{"alias_symbol":["SCF","SF","Kitl","KL-1","FPH2","SLF","DFNA69"],"prev_symbol":["MGF"]},"alphafold":{"accession":"P21583","domains":[{"cath_id":"1.20.1250.10","chopping":"27-157","consensus_level":"medium","plddt":85.3634,"start":27,"end":157},{"cath_id":"1.20.5","chopping":"232-273","consensus_level":"medium","plddt":64.8219,"start":232,"end":273}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P21583","model_url":"https://alphafold.ebi.ac.uk/files/AF-P21583-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P21583-F1-predicted_aligned_error_v6.png","plddt_mean":71.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KITLG","jax_strain_url":"https://www.jax.org/strain/search?query=KITLG"},"sequence":{"accession":"P21583","fasta_url":"https://rest.uniprot.org/uniprotkb/P21583.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P21583/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P21583"}},"corpus_meta":[{"pmid":"17637677","id":"PMC_17637677","title":"JAZ repressor proteins are targets of the SCF(COI1) complex during jasmonate signalling.","date":"2007","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/17637677","citation_count":1808,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20048001","id":"PMC_20048001","title":"A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP).","date":"2010","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/20048001","citation_count":1218,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24336215","id":"PMC_24336215","title":"D14-SCF(D3)-dependent degradation of D53 regulates strigolactone signalling.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/24336215","citation_count":635,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21368833","id":"PMC_21368833","title":"SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21368833","citation_count":564,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15571813","id":"PMC_15571813","title":"A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin.","date":"2004","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15571813","citation_count":394,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25394868","id":"PMC_25394868","title":"SCF ubiquitin ligase-targeted therapies.","date":"2014","source":"Nature reviews. Drug discovery","url":"https://pubmed.ncbi.nlm.nih.gov/25394868","citation_count":293,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15840441","id":"PMC_15840441","title":"Regulation of the cell cycle by SCF-type ubiquitin ligases.","date":"2005","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15840441","citation_count":284,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19483682","id":"PMC_19483682","title":"Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer.","date":"2009","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19483682","citation_count":269,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18988848","id":"PMC_18988848","title":"Identification of SCF ubiquitin ligase substrates by global protein stability profiling.","date":"2008","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/18988848","citation_count":175,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12795696","id":"PMC_12795696","title":"Protein interaction analysis of SCF ubiquitin E3 ligase subunits from Arabidopsis.","date":"2003","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12795696","citation_count":175,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15546359","id":"PMC_15546359","title":"The IAA1 protein is encoded by AXR5 and is a substrate of SCF(TIR1).","date":"2004","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15546359","citation_count":163,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11764276","id":"PMC_11764276","title":"Review: melanocyte migration and survival controlled by SCF/c-kit expression.","date":"2001","source":"The journal of investigative dermatology. Symposium proceedings","url":"https://pubmed.ncbi.nlm.nih.gov/11764276","citation_count":145,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9529603","id":"PMC_9529603","title":"Proteolysis and the G1-S transition: the SCF connection.","date":"1998","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/9529603","citation_count":140,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19616058","id":"PMC_19616058","title":"Molecular aspects of steroidogenic factor 1 (SF-1).","date":"2009","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19616058","citation_count":125,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29103612","id":"PMC_29103612","title":"Composition and Regulation of the Cellular Repertoire of SCF Ubiquitin Ligases.","date":"2017","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/29103612","citation_count":117,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9524767","id":"PMC_9524767","title":"Met-HGF/SF: tumorigenesis, invasion and metastasis.","date":"1997","source":"Ciba Foundation symposium","url":"https://pubmed.ncbi.nlm.nih.gov/9524767","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11861309","id":"PMC_11861309","title":"Requirement of Gab2 for mast cell development and KitL/c-Kit signaling.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11861309","citation_count":113,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17537799","id":"PMC_17537799","title":"Adrenal development is initiated by Cited2 and Wt1 through modulation of Sf-1 dosage.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17537799","citation_count":104,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10582239","id":"PMC_10582239","title":"SCF ubiquitin protein ligases and phosphorylation-dependent proteolysis.","date":"1999","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10582239","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16131838","id":"PMC_16131838","title":"Mechanisms of tumor suppression by the SCF(Fbw7).","date":"2005","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/16131838","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26868148","id":"PMC_26868148","title":"SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26868148","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9524773","id":"PMC_9524773","title":"HGF/SF in angiogenesis.","date":"1997","source":"Ciba Foundation symposium","url":"https://pubmed.ncbi.nlm.nih.gov/9524773","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14988407","id":"PMC_14988407","title":"Smad4 protein stability is regulated by ubiquitin ligase SCF beta-TrCP1.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14988407","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31898225","id":"PMC_31898225","title":"The Biology of F-box Proteins: The SCF Family of E3 Ubiquitin Ligases.","date":"2020","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/31898225","citation_count":86,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27156687","id":"PMC_27156687","title":"Recent advances in SCF ubiquitin ligase complex: Clinical implications.","date":"2016","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/27156687","citation_count":85,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11689688","id":"PMC_11689688","title":"Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11689688","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26818844","id":"PMC_26818844","title":"SCF(Cyclin F)-dependent degradation of CDC6 suppresses DNA re-replication.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26818844","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23528706","id":"PMC_23528706","title":"Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases.","date":"2013","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/23528706","citation_count":79,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23871831","id":"PMC_23871831","title":"A new mechanism of RhoA ubiquitination and degradation: roles of SCF(FBXL19) E3 ligase and Erk2.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23871831","citation_count":77,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24616269","id":"PMC_24616269","title":"DWARF3 participates in an SCF complex and associates with DWARF14 to suppress rice shoot branching.","date":"2014","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24616269","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10996795","id":"PMC_10996795","title":"The SCF ubiquitin ligase protein slimb regulates centrosome duplication in Drosophila.","date":"2000","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/10996795","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28218391","id":"PMC_28218391","title":"MAPK3/1 participates in the activation of primordial follicles through mTORC1-KITL signaling.","date":"2017","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28218391","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26674205","id":"PMC_26674205","title":"Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.","date":"2015","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26674205","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16824096","id":"PMC_16824096","title":"The Aspergillus nidulans F-box protein GrrA links SCF activity to meiosis.","date":"2006","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/16824096","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17166256","id":"PMC_17166256","title":"F-box proteins: more than baits for the SCF?","date":"2006","source":"Cell division","url":"https://pubmed.ncbi.nlm.nih.gov/17166256","citation_count":65,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27234298","id":"PMC_27234298","title":"SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development.","date":"2016","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/27234298","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23324393","id":"PMC_23324393","title":"An SCF complex containing Fbxl12 mediates DNA damage-induced Ku80 ubiquitylation.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23324393","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26522471","id":"PMC_26522471","title":"Allelic Mutations of KITLG, Encoding KIT Ligand, Cause Asymmetric and Unilateral Hearing Loss and Waardenburg Syndrome Type 2.","date":"2015","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26522471","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11076095","id":"PMC_11076095","title":"Stem cell factor (SCF) concentrations in peritoneal fluid of women with or without endometriosis.","date":"2000","source":"American journal of reproductive immunology (New York, N.Y. : 1989)","url":"https://pubmed.ncbi.nlm.nih.gov/11076095","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35484202","id":"PMC_35484202","title":"A conformational switch in the SCF-D3/MAX2 ubiquitin ligase facilitates strigolactone signalling.","date":"2022","source":"Nature plants","url":"https://pubmed.ncbi.nlm.nih.gov/35484202","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21368769","id":"PMC_21368769","title":"KITLG mutations cause familial progressive hyper- and hypopigmentation.","date":"2011","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/21368769","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15855639","id":"PMC_15855639","title":"SCF(beta-TrCP1) controls Smad4 protein stability in pancreatic cancer cells.","date":"2005","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15855639","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7529540","id":"PMC_7529540","title":"Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells.","date":"1994","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/7529540","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15917341","id":"PMC_15917341","title":"Analysis of hypomorphic KitlSl mutants suggests different requirements for KITL in proliferation and migration of mouse primordial germ cells.","date":"2005","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/15917341","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16570044","id":"PMC_16570044","title":"Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism.","date":"2006","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16570044","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20200142","id":"PMC_20200142","title":"Adrenocortical development and cancer: focus on SF-1.","date":"2010","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20200142","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23522382","id":"PMC_23522382","title":"Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.","date":"2013","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/23522382","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28656507","id":"PMC_28656507","title":"The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer.","date":"2017","source":"Journal of cell communication and signaling","url":"https://pubmed.ncbi.nlm.nih.gov/28656507","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34445249","id":"PMC_34445249","title":"The SCF Complex Is Essential to Maintain Genome and Chromosome Stability.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34445249","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20230746","id":"PMC_20230746","title":"Hsk1- and SCF(Pof3)-dependent proteolysis of S. pombe Ams2 ensures histone homeostasis and centromere function.","date":"2010","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/20230746","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26666832","id":"PMC_26666832","title":"SCF(β-TRCP) promotes cell growth by targeting PR-Set7/Set8 for degradation.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26666832","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25799412","id":"PMC_25799412","title":"SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25799412","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16905672","id":"PMC_16905672","title":"Association of genetic markers within the KIT and KITLG genes with human male infertility.","date":"2006","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16905672","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37028429","id":"PMC_37028429","title":"Systemwide disassembly and assembly of SCF ubiquitin ligase complexes.","date":"2023","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/37028429","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12429941","id":"PMC_12429941","title":"Seek and destroy: SCF ubiquitin ligases in mammalian cell cycle control.","date":"2002","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/12429941","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18448842","id":"PMC_18448842","title":"Involvement of the KIT/KITL signaling pathway in 4-vinylcyclohexene diepoxide-induced ovarian follicle loss in rats.","date":"2008","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/18448842","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23168267","id":"PMC_23168267","title":"Beyond steroidogenesis: novel target genes for SF-1 discovered by genomics.","date":"2012","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23168267","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19897599","id":"PMC_19897599","title":"SCF, BDNF, and Gas6 are regulators of growth plate chondrocyte proliferation and differentiation.","date":"2009","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19897599","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29149593","id":"PMC_29149593","title":"NOTCH2 Hajdu-Cheney Mutations Escape SCFFBW7-Dependent Proteolysis to Promote Osteoporosis.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29149593","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28406060","id":"PMC_28406060","title":"Auxin signaling through SCFTIR1/AFBs mediates feedback regulation of IAA biosynthesis.","date":"2017","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28406060","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29233834","id":"PMC_29233834","title":"The Arabidopsis ALF4 protein is a regulator of SCF E3 ligases.","date":"2017","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/29233834","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27108110","id":"PMC_27108110","title":"Stem Cell Factor (SCF) is a putative biomarker of antidepressant response.","date":"2016","source":"Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27108110","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19679664","id":"PMC_19679664","title":"Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19679664","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31451788","id":"PMC_31451788","title":"Notch and the pre-TCR coordinate thymocyte proliferation by induction of the SCF subunits Fbxl1 and Fbxl12.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31451788","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31936656","id":"PMC_31936656","title":"Pigment Intensity in Dogs is Associated with a Copy Number Variant Upstream of KITLG.","date":"2020","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/31936656","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26008799","id":"PMC_26008799","title":"Expression and localisation of c-kit and KITL in the adult human ovary.","date":"2015","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/26008799","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32032354","id":"PMC_32032354","title":"Skp, Cullin, F-box (SCF)-Met30 and SCF-Cdc4-Mediated Proteolysis of CENP-A Prevents Mislocalization of CENP-A for Chromosomal Stability in Budding Yeast.","date":"2020","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32032354","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31289136","id":"PMC_31289136","title":"SCFFBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31289136","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27238229","id":"PMC_27238229","title":"Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery.","date":"2016","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/27238229","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24038146","id":"PMC_24038146","title":"PLCγ2 and PKC are important to myeloid lineage commitment triggered by M-SCF and G-CSF.","date":"2014","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24038146","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25204433","id":"PMC_25204433","title":"Isoform-specific SCF(Fbw7) ubiquitination mediates differential regulation of PGC-1α.","date":"2015","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25204433","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29567944","id":"PMC_29567944","title":"Insulin Regulates Adrenal Steroidogenesis by Stabilizing SF-1 Activity.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29567944","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29496961","id":"PMC_29496961","title":"MAPK signaling couples SCF-mediated degradation of translational regulators to oocyte meiotic progression.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29496961","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31434494","id":"PMC_31434494","title":"SCF (Stem Cell Factor) and cKIT Modulate Pathological Ocular Neovascularization.","date":"2019","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31434494","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30655559","id":"PMC_30655559","title":"The circadian E3 ligase complex SCFFBXL3+CRY targets TLK2.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30655559","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28892167","id":"PMC_28892167","title":"Effect of cadmium on kitl pre-mRNA alternative splicing in murine ovarian granulosa cells and its associated regulation by miRNAs.","date":"2017","source":"Journal of applied toxicology : JAT","url":"https://pubmed.ncbi.nlm.nih.gov/28892167","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21233843","id":"PMC_21233843","title":"TAK1 regulates SCF expression to modulate PKBα activity that protects keratinocytes from ROS-induced apoptosis.","date":"2011","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/21233843","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37063428","id":"PMC_37063428","title":"SCF/c-Kit-activated signaling and angiogenesis require Gαi1 and Gαi3.","date":"2023","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37063428","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16373964","id":"PMC_16373964","title":"Molecular characterization of PDGFR-alpha/PDGF-A and c-KIT/SCF in gliosarcomas.","date":"2005","source":"Cellular oncology : the official journal of the International Society for Cellular Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16373964","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15475566","id":"PMC_15475566","title":"A specific endoplasmic reticulum export signal drives transport of stem cell factor (Kitl) to the cell surface.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15475566","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25425648","id":"PMC_25425648","title":"Ubiquitin-conjugating enzyme Cdc34 and ubiquitin ligase Skp1-cullin-F-box ligase (SCF) interact through multiple conformations.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25425648","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25488359","id":"PMC_25488359","title":"Nobiletin, a polymethoxy flavonoid, reduced endothelin-1 plus SCF-induced pigmentation in human melanocytes.","date":"2015","source":"Photochemistry and photobiology","url":"https://pubmed.ncbi.nlm.nih.gov/25488359","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31613171","id":"PMC_31613171","title":"MiR-27a regulates WNT3A and KITLG expression in Cashmere goats with different coat colors.","date":"2019","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/31613171","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22454292","id":"PMC_22454292","title":"DEPTOR ubiquitination and destruction by SCF(β-TrCP).","date":"2012","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22454292","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12242244","id":"PMC_12242244","title":"An allelic series of mutations in the kit ligand gene of mice. I. Identification of point mutations in seven ethylnitrosourea-induced Kitl(Steel) alleles.","date":"2002","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12242244","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33156518","id":"PMC_33156518","title":"SCFSNIPER7 controls protein turnover of unfoldase CDC48A to promote plant immunity.","date":"2020","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/33156518","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22221032","id":"PMC_22221032","title":"Polymorphism identification in the goat KITLG gene and association analysis with litter size.","date":"2011","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22221032","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25704143","id":"PMC_25704143","title":"Cep68 can be regulated by Nek2 and SCF complex.","date":"2015","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/25704143","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39880951","id":"PMC_39880951","title":"C-terminal amides mark proteins for degradation via SCF-FBXO31.","date":"2025","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/39880951","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35140718","id":"PMC_35140718","title":"Autocrine/Paracrine Loop Between SCF+/c-Kit+ Mast Cells Promotes Cutaneous Melanoma Progression.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35140718","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29099936","id":"PMC_29099936","title":"Genomic Analysis Suggests KITLG is Responsible for a Roan Pattern in two Pakistani Goat Breeds.","date":"2018","source":"The Journal of heredity","url":"https://pubmed.ncbi.nlm.nih.gov/29099936","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30762924","id":"PMC_30762924","title":"Spironolactone-induced XPB degradation depends on CDK7 kinase and SCFFBXL18 E3 ligase.","date":"2019","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/30762924","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15986847","id":"PMC_15986847","title":"Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer.","date":"2005","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15986847","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30209188","id":"PMC_30209188","title":"Bmi1 Regulates IκBα Degradation via Association with the SCF Complex.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30209188","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26500786","id":"PMC_26500786","title":"NRG1 and KITL Signal Downstream of Retinoic Acid in the Germline to Support Soma-Free Syncytial Growth of Differentiating Spermatogonia.","date":"2015","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/26500786","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26400522","id":"PMC_26400522","title":"DNA damage regulates ARID1A stability via SCF ubiquitin ligase in gastric cancer cells.","date":"2015","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26400522","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25449280","id":"PMC_25449280","title":"Stem cell factor (SCF) protects osteoblasts from oxidative stress through activating c-Kit-Akt signaling.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25449280","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35231559","id":"PMC_35231559","title":"TDP-43 is a ubiquitylation substrate of the SCFcyclin F complex.","date":"2022","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/35231559","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37339624","id":"PMC_37339624","title":"Structural and mechanistic insights into the CAND1-mediated SCF substrate receptor exchange.","date":"2023","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/37339624","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21710433","id":"PMC_21710433","title":"Regulation of cell fate determination by Skp1-Cullin1-F-box (SCF) E3 ubiquitin ligases.","date":"2011","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21710433","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2208279","id":"PMC_2208279","title":"Primary structure and functional expression of rat and human stem cell factor DNAs.","date":"1990","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/2208279","citation_count":795,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16616334","id":"PMC_16616334","title":"Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain.","date":"2006","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/16616334","citation_count":692,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9269751","id":"PMC_9269751","title":"Stem cell factor and hematopoiesis.","date":"1997","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9269751","citation_count":644,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17952075","id":"PMC_17952075","title":"Genetic determinants of hair, eye and skin pigmentation in Europeans.","date":"2007","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17952075","citation_count":538,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28714970","id":"PMC_28714970","title":"Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF.","date":"2017","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28714970","citation_count":408,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9113989","id":"PMC_9113989","title":"P110delta, a novel phosphoinositide 3-kinase in leukocytes.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9113989","citation_count":383,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15526160","id":"PMC_15526160","title":"Signal transduction via the stem cell factor receptor/c-Kit.","date":"2004","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/15526160","citation_count":352,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1378327","id":"PMC_1378327","title":"Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2.","date":"1992","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/1378327","citation_count":287,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20543847","id":"PMC_20543847","title":"Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20543847","citation_count":278,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18083106","id":"PMC_18083106","title":"cis-Regulatory changes in Kit ligand expression and parallel evolution of pigmentation in sticklebacks and humans.","date":"2007","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18083106","citation_count":276,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17662946","id":"PMC_17662946","title":"Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.","date":"2007","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17662946","citation_count":271,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23222517","id":"PMC_23222517","title":"Seventy-five genetic loci influencing the human red blood cell.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23222517","citation_count":266,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19483681","id":"PMC_19483681","title":"A genome-wide association study of testicular germ cell tumor.","date":"2009","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19483681","citation_count":261,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17207965","id":"PMC_17207965","title":"hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17207965","citation_count":222,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8547494","id":"PMC_8547494","title":"Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos.","date":"1995","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/8547494","citation_count":185,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12753403","id":"PMC_12753403","title":"The role of Kit-ligand in melanocyte development and epidermal homeostasis.","date":"2003","source":"Pigment cell research","url":"https://pubmed.ncbi.nlm.nih.gov/12753403","citation_count":182,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14985355","id":"PMC_14985355","title":"Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14985355","citation_count":176,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23666239","id":"PMC_23666239","title":"Meta-analysis identifies four new loci associated with testicular germ cell tumor.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23666239","citation_count":140,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12481031","id":"PMC_12481031","title":"CUL7: A DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12481031","citation_count":136,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24880339","id":"PMC_24880339","title":"A molecular basis for classic blond hair color in Europeans.","date":"2014","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24880339","citation_count":134,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15217825","id":"PMC_15217825","title":"Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15217825","citation_count":133,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17556598","id":"PMC_17556598","title":"Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis.","date":"2007","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/17556598","citation_count":133,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46349,"output_tokens":4562,"usd":0.103738},"stage2":{"model":"claude-opus-4-6","input_tokens":8117,"output_tokens":2807,"usd":0.16614},"total_usd":0.650326,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":58472,"output_tokens":7753,"usd":0.145855},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":10619,"output_tokens":4132,"usd":0.234593}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2015,\n      \"finding\": \"Truncating and missense mutations in KITLG cause non-syndromic unilateral/asymmetric hearing loss and Waardenburg syndrome type 2. In vitro studies showed that the p.His67_Cys68delinsArg transmembrane isoform of KITLG is not detectable at the cell membrane, while the p.Leu104Val isoform reaches the membrane but secretes reduced soluble KITLG, indicating loss-of-function versus dominant-negative/gain-of-function mechanisms respectively.\",\n      \"method\": \"In vitro cell transfection with mutant KITLG constructs, cell surface detection assays, ELISA for secreted soluble isoforms\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional in vitro characterization of mutant proteins with cell surface and secretion assays, single study\",\n      \"pmids\": [\"26522471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Intracellular transport of KITLG (Kit ligand/stem cell factor) to the cell surface is controlled at the level of the endoplasmic reticulum and requires a C-terminal valine residue in the cytoplasmic tail positioned 19–36 amino acids from the transmembrane domain border. This valine acts as an ER export signal mediating recruitment into COPII-coated ER exit sites; deletion or substitution abolishes efficient ER-to-Golgi transport and reduces cell surface presentation.\",\n      \"method\": \"Mutagenesis of cytoplasmic tail, live-cell imaging with GFP-tagged KITLG and temperature-sensitive VSVG fusion construct, subcellular fractionation, COPII vesicle recruitment assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with live-cell imaging and functional transport assays in a single rigorous study\",\n      \"pmids\": [\"15475566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Gab2, an adaptor molecule, is required for KitL/c-Kit signaling in mast cell development. Gab2-deficient mice show markedly reduced mast cell numbers, and bone marrow-derived mast cells from these mice show impaired KitL-induced ERK MAP kinase and Akt activation.\",\n      \"method\": \"Gab2 knockout mouse generation, KitL stimulation assays, Western blot for ERK and Akt phosphorylation, mast cell enumeration\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and signaling phenotype, replicated across multiple tissues\",\n      \"pmids\": [\"11861309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SCF/c-Kit signaling and spatiotemporally specific KITLG (SCF) ligand expression regulate melanocyte migration and survival. Analysis of Sl and W mutant mice and SCF transgene expression demonstrated that KITLG acts through c-Kit to control distinct stages of melanocyte development, and that c-Kit-independent melanocyte stem cells exist in postnatal skin.\",\n      \"method\": \"Analysis of Sl/W mutant mice, functional blockade with anti-c-Kit monoclonal antibody, SCF transgene expression in mice\",\n      \"journal\": \"The journal of investigative dermatology. Symposium proceedings\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function and transgenic gain-of-function with defined cellular phenotypes, replicated across multiple mutant backgrounds\",\n      \"pmids\": [\"11764276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Comparison of hypomorphic KitlSl mutations reveals that different levels of KITL function are required for primordial germ cell (PGC) proliferation versus migration, and that requirements for KITL in proliferation differ before and after PGCs begin migrating.\",\n      \"method\": \"Allelic series of ENU-induced and other Kitl hypomorphic mutations in mice, analysis of PGC number and position at multiple developmental stages\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic allelic series with defined phenotypic readouts, single lab\",\n      \"pmids\": [\"15917341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ENU mutagenesis identified seven Kitl(Steel) alleles with point mutations in Kit ligand; five missense mutations affect residues within or near conserved alpha-helical domains of Kitl, defining structural requirements for Kitl function.\",\n      \"method\": \"ENU mutagenesis, sequencing of Kitl alleles, structural analysis of mutation positions relative to helical cytokine domains\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic allelic series with structural interpretation, single lab\",\n      \"pmids\": [\"12242244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"KITLG mutations (p.Val33Ala and p.Thr34Pro in a conserved β-strand) cause familial progressive hyper- and hypopigmentation (FPHH), suggesting that the β-strand is important for activation of the KITLG receptor c-Kit and that mutations in KITLG can cause multiple distinct pigmentation disorders.\",\n      \"method\": \"Genome-wide linkage analysis, sequencing of KITLG in affected families, cosegregation analysis\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — genetic linkage and mutation identification without direct functional in vitro assay of mutant proteins\",\n      \"pmids\": [\"21368769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MAPK3/1 (ERK1/2) participates in the activation of primordial follicles through mTORC1-KITL signaling. Inhibition of MAPK3/1 with U0126 reduced follicle activation and decreased phosphorylation of TSC2, S6K1, rpS6, and expression of KITL in granulosa cells, placing MAPK3/1 upstream of mTORC1-KITL signaling in primordial follicle activation.\",\n      \"method\": \"Ex vivo ovary culture with MAPK3/1 inhibitor U0126, Western blot for mTORC1 pathway components and KITL expression, immunofluorescence, follicle counting\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological epistasis in organ culture with multiple signaling readouts, single lab\",\n      \"pmids\": [\"28218391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"KIT/KITL signaling is critical for follicular survival in primordial and primary follicles. VCD-induced ovotoxicity in rats was associated with decreased Kit and increased Kitl expression; adding exogenous KITL to ovarian cultures attenuated VCD-induced follicle loss.\",\n      \"method\": \"In vivo VCD dosing and in vitro ovarian culture, microarray, RT-PCR, Western blot, addition of exogenous KITL protein\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — rescue experiment with exogenous KITL plus expression profiling, single lab\",\n      \"pmids\": [\"18448842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SCF (stem cell factor/KITLG) and cKIT modulate pathological ocular neovascularization. Mechanistically, SCF/cKIT signaling induces neovascularization through phosphorylation of GSK-3β and enhancement of nuclear translocation of β-catenin and transcription of β-catenin target genes related to angiogenesis. Blockade of β-catenin-mediated transcription blocked SCF-induced in vitro angiogenesis.\",\n      \"method\": \"cKit mutant mice, anti-SCF neutralizing IgG, oxygen-induced retinopathy and laser-induced choroidal neovascularization models, Western blot for GSK-3β phosphorylation and β-catenin nuclear translocation, β-catenin inhibitors\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic and pharmacological epistasis with defined molecular mechanism, multiple orthogonal approaches\",\n      \"pmids\": [\"31434494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SCF/c-Kit-activated downstream signaling and angiogenesis require Gαi1 and Gαi3 proteins. Gαi1/3 associates with SCF-activated c-Kit, promotes c-Kit endocytosis and adaptor protein binding, and transduces Akt-mTOR and ERK signaling. Endothelial knockdown of Gαi1/3 in vivo suppressed SCF-induced retinal angiogenesis.\",\n      \"method\": \"Co-IP, siRNA knockdown, Gαi1/3 KO, dominant negative mutants, overexpression, in vivo AAV-shRNA endothelial knockdown in retinal angiogenesis model, Western blot for Akt-mTOR and ERK activation\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KO, KD, DN mutants, OE) in vitro and in vivo, single lab\",\n      \"pmids\": [\"37063428\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SCF (KITLG) is a downstream transcriptional target of HIF-1α in pancreatic ductal adenocarcinoma cells under hypoxia. HIF-1α directly binds to the hypoxia response element (HRE) in the SCF promoter to activate SCF transcription, and SCF promotes PDAC cell proliferation and invasion under hypoxia.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, HIF-1α siRNA knockdown, Western blot, colony formation, scratch and transwell invasion assay, in vivo xenograft with digoxin inhibition of HIF-1α\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and luciferase confirm direct HIF-1α binding to KITLG promoter, functional rescue with exogenous SCF, single lab\",\n      \"pmids\": [\"25799412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TAK1 directly regulates SCF (stem cell factor/KITLG) expression in keratinocytes to activate PKBα/Akt pro-survival signaling in a cell-autonomous manner, protecting keratinocytes from ROS-induced apoptosis. Ectopic expression of TAK1 or treatment with exogenous SCF restored increased ROS and apoptosis in TAK1-deficient keratinocytes.\",\n      \"method\": \"TAK1 knockout keratinocytes, organotypic skin co-culture, growth factor array, ectopic TAK1 expression, exogenous SCF rescue, pharmacological inhibitors of SCF/c-Kit/PKBα pathway\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with rescue experiments, pathway epistasis, single lab\",\n      \"pmids\": [\"21233843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SCF (KITLG) protects osteoblasts from oxidative stress through activation of c-Kit and downstream Akt signaling. c-Kit is functionally expressed in osteoblasts; pharmacological inhibition or shRNA knockdown of c-Kit abolished SCF-mediated cytoprotection against H2O2, and inhibition of Akt suppressed SCF-mediated anti-H2O2 activity.\",\n      \"method\": \"Pharmacological inhibitors (Imatinib, Dasatinib), shRNA knockdown of c-Kit and Akt, H2O2 cytotoxicity assay in MC3T3-E1 cells and primary osteoblasts\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological and genetic knockdown with defined signaling pathway, single lab\",\n      \"pmids\": [\"25449280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SCF (KITLG) and its receptor KIT are regulators of growth plate chondrocyte differentiation. SCF inhibits IGF-I-mediated chondrocyte proliferation by attenuating ERK1/2 activation, and promotes differentiation in ATDC5 cells with distinct expression patterns for collagen X, collagen 2, aggrecan, and lysyl oxidase.\",\n      \"method\": \"Proliferation assay of isolated chondrocytes, differentiation assay in ATDC5 cells, Western blot for ERK1/2 activation\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional assays with defined signaling readout, single lab\",\n      \"pmids\": [\"19897599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-34c targets KITLG as part of resveratrol's anti-colorectal cancer mechanism. Resveratrol upregulates miR-34c (via promoter demethylation), which knocks down KITLG expression; overexpression or inhibition of miR-34c correspondingly modulates KITLG levels and CRC cell proliferation, migration, invasion, and apoptosis.\",\n      \"method\": \"miR-34c lentiviral overexpression and inhibitor, qPCR and Western blot for KITLG, methylation-specific PCR, cell viability, colony formation, flow cytometry, transwell migration, xenograft model\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional manipulation of miR-34c with KITLG as validated target, in vitro and in vivo, single lab\",\n      \"pmids\": [\"26674205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NRG1 and KITL signal downstream of retinoic acid in the germline via alternative pathways to support spermatogonial differentiation. KITL-dependent spermatogonial development is not disrupted by ERBB2 inhibitors and KITL rescues ERBB3-deficient spermatogonial degeneration upon differentiation, placing KITL in an ERBB2/3-independent pathway downstream of retinoic acid.\",\n      \"method\": \"Soma-free rat spermatogonial culture, ERBB2 pharmacological inhibitors, ERBB3-deficient germline, exogenous KITL protein addition, differentiation assays\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological epistasis in defined culture system, single lab\",\n      \"pmids\": [\"26500786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A copy number variant (CNV) approximately 152 kb upstream of KITLG is associated with pigment intensity in dogs. Increased copy number correlates with darker coat color in multiple breeds and along the hair shaft in both pheomelanin and eumelanin coats, consistent with a cis-regulatory role of KITLG in melanogenesis.\",\n      \"method\": \"GWAS, whole genome sequencing coverage analysis, digital droplet PCR genotyping, association analysis across breeds\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — genetic association without direct functional mechanistic assay of KITLG protein\",\n      \"pmids\": [\"31936656\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KITLG (stem cell factor/SCF) is a dimeric transmembrane and soluble ligand for the c-Kit receptor tyrosine kinase whose cell-surface transport is controlled by a C-terminal valine ER export signal; upon binding c-Kit, it activates multiple downstream pathways including PI3K-Akt, ERK/MAPK, and GSK-3β/β-catenin to regulate survival, proliferation, migration, and differentiation of melanocytes, mast cells, primordial germ cells, hematopoietic stem cells, and other cell types, with adaptor proteins Gab2 and Gαi1/3 serving as essential signal transducers, and its expression regulated transcriptionally by HIF-1α and TAK1 and post-transcriptionally by miRNAs such as miR-34c.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nLooking at the corpus, I need to classify papers as KEEP (about KITLG/SCF=stem cell factor/Kit ligand) or EXCLUDE (about SCF=Skp1-Cullin-F-box ubiquitin ligase complexes, or other unrelated topics).\n\nThe vast majority of papers [1]-[7], [9]-[11], [13], [15], [19]-[29] etc. in the first set are about SCF ubiquitin ligase complexes — this is an alias collision (SCF = Skp1-Cullin-F-box, not stem cell factor). I need to carefully identify only papers about KITLG (KIT ligand/stem cell factor).\n\nKEEP papers (about KITLG protein):\n- [8] KITLG GWAS/TGCT\n- [12] SCF/c-kit melanocyte migration (KITLG context)\n- [17] Gab2/KitL/c-Kit signaling\n- [32] MAPK3/1-mTORC1-KITL signaling in primordial follicle activation\n- [33] miR-34c-KITLG in colorectal cancer\n- [38] KITLG mutations causing hearing loss/WS2\n- [39] SCF in peritoneal fluid/endometriosis\n- [41] KITLG mutations/pigmentation\n- [43] SCF/c-kit in multiple myeloma\n- [44] KitlSl mutations/PGC migration and proliferation\n- [45] SCF/KIT in GISTs (autocrine/paracrine)\n- [48] SCF/c-KIT signaling in testis/prostate cancer\n- [52] SCF/HIF-1α in pancreatic cancer\n- [53] KIT/KITLG in male infertility\n- [56] KIT/KITL signaling in ovarian follicle loss\n- [58] SCF in growth plate chondrocytes\n- [62] SCF as biomarker of antidepressant response\n- [65] CNV upstream of KITLG/pigmentation in dogs\n- [66] c-kit/KITL in human ovary\n- [74] SCF/cKIT in ocular neovascularization\n- [76] cadmium/kitl pre-mRNA splicing\n- [77] TAK1 regulates SCF expression/keratinocytes\n- [78] SCF/c-Kit signaling/Gαi proteins/angiogenesis\n- [80] ER export signal in Kitl\n- [82] Nobiletin/ET+SCF-induced pigmentation\n- [83] miR-27a/KITLG in goat coat color\n- [85] Allelic series of Kitl mutations in mice\n- [87] KITLG polymorphisms/litter size in goats\n- [90] SCF+/c-Kit+ mast cells in melanoma\n- [91] KITLG and roan pattern in goats\n- [95] NRG1/KITL signal in spermatogonial differentiation\n- [97] SCF/c-Kit-Akt in osteoblasts\n\nGene2pubmed curated KEEP:\n- [4] Primary structure of SCF/KITLG\n- [9] Stem cell factor and hematopoiesis (review)\n- [10] KITLG SNP associated with hair color\n- [12] Bone marrow adipocytes secrete SCF\n- [14] Signal transduction via c-Kit/SCF\n- [15] KL-1 and KL-2 isoforms of kit-ligand\n- [17] cis-regulatory changes in Kitlg/pigmentation\n- [18] Crystal structure of KIT ectodomain activated by SCF\n- [22] SCF expression in preimplantation embryos\n- [23] Kit-ligand in melanocyte development\n- [24] SCF/c-kit in endothelial cells/angiogenesis\n- [28] KITLG regulatory enhancer/blond hair color\n- [29] Kit and FcεRI signaling in mast cells\n- [30] SCF role in hematopoiesis from hESCs\n- [13] p110delta PI3K/SCF signaling in leukocytes\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1990,\n      \"finding\": \"KITLG (stem cell factor/SCF) was cloned from rat and human; truncated recombinant forms expressed in E. coli and mammalian cells retained biological activity, augmenting proliferation of myeloid and lymphoid hematopoietic progenitors in bone marrow cultures and showing synergy with colony-stimulating factors.\",\n      \"method\": \"cDNA cloning, recombinant protein expression, hematopoietic progenitor proliferation assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original cloning with functional in vitro validation, foundational paper\",\n      \"pmids\": [\"2208279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"KITLG is produced as two transmembrane isoforms (KL-1 and KL-2) generated by alternative splicing. KL-1 is efficiently cleaved at the cell surface to produce soluble KL; KL-2 lacks the major proteolytic cleavage site (removed by splicing) and is shed with reduced efficiency. Phorbol ester and calcium ionophore induce cleavage of both isoforms at similar rates, indicating regulated shedding. The relative abundance of KL-1 vs KL-2 is controlled in a tissue-specific manner.\",\n      \"method\": \"Alternative splicing analysis, phorbol ester/calcium ionophore treatment, Western blot, cell surface cleavage assays\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal biochemical methods, replicated across isoforms\",\n      \"pmids\": [\"1378327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Gab2, an adaptor molecule with a pleckstrin homology domain, is required for KitL/c-Kit signaling and mast cell development. In Gab2-deficient mice, mast cell numbers were markedly reduced, and bone marrow-derived mast cells grew poorly in response to KitL. KitL-induced ERK MAP kinase and Akt activation were impaired in Gab2-deficient cells, placing Gab2 downstream of KitL/c-Kit and upstream of ERK and PI3K/Akt pathways.\",\n      \"method\": \"Gab2 knockout mouse, bone marrow-derived mast cell cultures, kinase activation assays (ERK, Akt Western blot)\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and biochemical phenotype, multiple downstream readouts\",\n      \"pmids\": [\"11861309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"A C-terminal valine residue in the cytoplasmic tail of Kitl (positioned 19–36 amino acids from the transmembrane/cytoplasmic domain border) acts as a specific ER export signal. Deletion or substitution of this valine causes ER accumulation of Kitl and reduced cell surface transport. The valine-dependent motif recruits Kitl into COPII-coated ER exit sites for vesicular ER-to-Golgi transport.\",\n      \"method\": \"Mutagenesis, live-cell imaging with GFP fusion and ts-VSV-G reporter, subcellular fractionation, fluorescence microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis combined with live imaging and functional localization, mechanistically rigorous\",\n      \"pmids\": [\"15475566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SCF/c-Kit signaling promotes survival, migration, and capillary tube formation of human umbilical vein endothelial cells by rapidly activating Akt, Erk1/2, and c-Kit tyrosine phosphorylation. PI3K inhibitors (wortmannin, LY294002) and MEK inhibitor (PD98059) abrogated survival and tube formation, and c-Kit inhibitor STI-571 blocked these effects, demonstrating that the SCF/c-Kit → PI3K/Akt and Erk1/2 axes mediate endothelial cell survival and morphogenesis.\",\n      \"method\": \"Pharmacological inhibitors, c-Kit phosphorylation assays, cell survival/migration/tube formation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple inhibitors and orthogonal functional assays with defined pathway placement\",\n      \"pmids\": [\"14985355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"c-Kit activation by SCF in mast cells uniquely activates STAT5 and STAT6 phosphorylation, while FcεRI uniquely activates PKC-dependent c-Jun/AP-1 induction. Both receptors converge on PI3K/Akt and MAPK. Kit ligand failed to induce degranulation alone but strongly synergized with antigen, and continuous KL exposure down-regulated signals that were reactivated by antigen co-stimulation.\",\n      \"method\": \"Phospho-specific Western blotting, cytokine transcript quantification, degranulation assays in human mast cells from CD34+ progenitors\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple signaling readouts in primary human cells with pharmacological and genetic dissection\",\n      \"pmids\": [\"15217825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Analysis of an allelic series of hypomorphic KitlSl mutations in mice revealed that KITL requirements differ during PGC development: proliferation before and after migration requires different levels of KITL function, and different threshold levels of KITL support proliferation versus migration of primordial germ cells.\",\n      \"method\": \"ENU-induced hypomorphic allele series, genetic comparison of PGC numbers at developmental stages, histology\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple alleles with graded phenotypes enabling dissection of function, but no direct biochemical mechanistic assay\",\n      \"pmids\": [\"15917341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"KIT is activated in all GISTs examined, even without KIT mutations. Both membrane-bound and soluble SCF mRNA isoforms are co-expressed in GIST cells and primary cultures, and SCF protein is detected within GIST cells, suggesting an autocrine/paracrine mechanism of KIT activation by KITLG.\",\n      \"method\": \"RT-PCR, ELISA, immunohistochemistry, Western blotting for phospho-KIT, primary GIST cell cultures\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-expression and protein detection without genetic perturbation of the loop\",\n      \"pmids\": [\"16570044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structures of the entire KIT ectodomain before and after SCF stimulation showed that SCF binding drives KIT dimerization, with SCF's sole role being to bring two KIT molecules into proximity. Receptor dimerization induces conformational changes enabling lateral interactions between membrane-proximal Ig-like domains D4 and D5 of two KIT molecules. Point mutations in D4-D4 contact residues compromised KIT activation in cultured cells, and oncogenic mutations map to the D5-D5 interface.\",\n      \"method\": \"X-ray crystallography, site-directed mutagenesis, cell-based KIT activation assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with mutagenesis validation in cells, highly cited foundational structural paper\",\n      \"pmids\": [\"17662946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"cis-regulatory changes in the Kitlg gene underlie parallel evolution of reduced pigmentation in sticklebacks and contribute to human skin color variation. A divergent regulatory allele of Kitlg reduces expression in gill and skin tissue in freshwater sticklebacks, and admixture mapping confirmed the KITLG genomic region affects human skin color. The regulatory changes rather than coding changes drive pigmentation differences.\",\n      \"method\": \"Genetic crosses, high-resolution mapping, expression studies, admixture mapping in humans\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic mapping combined with expression and functional evidence across species\",\n      \"pmids\": [\"18083106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SCF (KITLG) overexpressed by neurons following brain injury and by glioma cells directly activates brain microvascular endothelial cells in vitro and induces angiogenesis in vivo. SCF downregulation inhibited tumor-mediated angiogenesis and glioma growth in vivo.\",\n      \"method\": \"In vitro endothelial cell activation assays, in vivo glioma xenograft models with SCF downregulation (shRNA), immunohistochemistry\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function in vivo with defined angiogenic phenotype\",\n      \"pmids\": [\"16616334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"VCD-induced ovarian follicle loss is associated with decreased Kit mRNA/protein and increased Kitl mRNA/protein expression. Addition of exogenous KITL to ovarian cultures during VCD exposure attenuated follicle loss, supporting that KIT/KITL signaling is critical for primordial and primary follicle survival and that VCD compromises this pathway.\",\n      \"method\": \"Microarray, RT-PCR, Western blot, in vitro ovarian culture with growth factor rescue experiments\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — rescue experiment provides functional evidence but mechanism is inferred\",\n      \"pmids\": [\"18448842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SCF inhibits IGF-I-mediated proliferation of growth plate chondrocytes by attenuating ERK1/2 activation, and promotes chondrocyte differentiation in ATDC5 cells with distinct expression patterns for collagen X, collagen 2, aggrecan, and lysyl oxidase.\",\n      \"method\": \"Isolated bovine chondrocyte proliferation assays, ATDC5 differentiation assays, ERK1/2 phosphorylation Western blots\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct cell-based assays with defined signaling readout, but single laboratory\",\n      \"pmids\": [\"19897599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TAK1 directly regulates SCF (KITLG) expression, which activates the PKBα (Akt) pro-survival pathway in keratinocytes to protect them from ROS-mediated apoptosis. TAK1 deficiency led to increased apoptosis and elevated ROS. Ectopic TAK1 expression or exogenous SCF restored this phenotype, and inhibition of SCF/c-Kit/PKBα pathway increased ROS and apoptosis in normal keratinocytes.\",\n      \"method\": \"TAK1 knockdown/overexpression, recombinant SCF rescue, pharmacological inhibitors of c-Kit/PKBα, FACS for ROS and apoptosis, organotypic skin culture\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple complementary approaches with gain- and loss-of-function and rescue, defining pathway placement\",\n      \"pmids\": [\"21233843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"KITLG mutations cause familial progressive hyper- and hypopigmentation (FPHH): three mutations identified in conserved β-strand of KITLG. In vitro studies showed the p.His67_Cys68delinsArg transmembrane isoform is undetectable at the cell membrane, while p.Leu104Val is membrane-located but reduces soluble KITLG secretion. These data suggest NS-UHL/AHL mutations cause loss-of-function, while the WS2 mutation may act via dominant-negative or gain-of-function through altered membrane incorporation and reduced secretion.\",\n      \"method\": \"Whole-exome sequencing, linkage analysis, in vitro cell membrane localization assays, secretion assays\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro functional studies of specific mutations with defined localization and secretion readouts\",\n      \"pmids\": [\"21368769\", \"26522471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A molecular basis for blond hair color in northern Europeans was identified: a regulatory enhancer within the KITLG locus contains the SNP rs12821256 that alters a LEF1 (lymphoid enhancer-binding factor 1) transcription factor binding site, reducing LEF1 responsiveness and enhancer activity in keratinocytes. Mice carrying the derived human KITLG enhancer variant show significantly reduced hair pigmentation, confirming that cis-regulatory reduction of KITLG expression drives the blond hair phenotype.\",\n      \"method\": \"Functional enhancer assays in keratinocytes, LEF1 binding site mutagenesis, transgenic mouse enhancer knock-in experiments\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — enhancer assays, mutagenesis of transcription factor binding site, and in vivo mouse confirmation\",\n      \"pmids\": [\"24880339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"KITLG is a direct target of miR-34c in colorectal cancer cells. Resveratrol upregulates miR-34c (via promoter demethylation), which knocks down KITLG and suppresses CRC cell viability, proliferation, migration, invasion and promotes apoptosis. The effect was enhanced in p53-positive cells and likely involves PI3K/Akt pathway inactivation. In vivo, resveratrol elevated miR-34c and reduced KITLG in xenografts.\",\n      \"method\": \"Luciferase reporter assay (miR-34c targeting KITLG 3'UTR), lentiviral miR-34c overexpression/inhibition, MSP for methylation, xenograft models\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct miRNA-target validation by luciferase reporter with in vivo confirmation, but pathway placement is partially inferred\",\n      \"pmids\": [\"26674205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"KITLG mRNA is expressed as two isoforms (KITL1 and KITL2) in the adult human ovary, with both KITL protein isoforms present in granulosa cells and ovarian cortex. c-Kit and KITL proteins are expressed in multiple follicle cell types (granulosa, theca, stromal) throughout folliculogenesis, and oocytes express c-kit exclusively. Unlike animal models, expression of both proteins is less cell-type specific in humans, suggesting autocrine signaling occurs within the human ovary.\",\n      \"method\": \"RT-PCR for isoform detection, Western blot, immunohistochemistry in human ovarian tissue\",\n      \"journal\": \"Journal of ovarian research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — descriptive localization in human tissue without functional perturbation\",\n      \"pmids\": [\"26008799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MAPK3/1 (ERK1/2) participates in primordial follicle activation through the mTORC1-KITL signaling pathway in pre-granulosa cells. MAPK3/1 inhibitor U0126 reduced follicle activation, decreased phosphorylation of TSC2, S6K1, rpS6, and reduced KITL expression. U0126 also decreased Akt phosphorylation and blocked Foxo3 nuclear export in oocytes, placing MAPK3/1 upstream of mTORC1-KITL in granulosa cells and KIT-PI3K signaling in oocytes.\",\n      \"method\": \"Ex vivo ovarian culture with MAPK3/1 inhibitor, Western blot for mTORC1 components, KITL expression analysis, PTEN inhibitor co-experiments, immunofluorescence for Foxo3 localization\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological dissection with multiple pathway readouts, but reliance on inhibitors\",\n      \"pmids\": [\"28218391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Bone marrow adipocytes synthesize SCF (KITLG) and promote HSC maintenance and haematopoietic regeneration after irradiation or chemotherapy. Adipocyte-specific Scf deletion (using Adipoq-Cre/ER) inhibited haematopoietic regeneration, depleted HSCs (in tail vertebrae with abundant adipocytes), and reduced mouse survival after irradiation. SCF from LepR+ stromal cells also promoted regeneration.\",\n      \"method\": \"Conditional knockout (Adipoq-Cre/ER-driven Scf deletion), irradiation/5-FU models, HSC frequency measurement, survival curves\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with defined cellular phenotype (HSC depletion, reduced survival), replicated with LepR+ deletion\",\n      \"pmids\": [\"28714970\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SCF/cKIT signaling induces pathological ocular neovascularization through phosphorylation of glycogen synthase kinase-3β (GSK-3β) and enhancement of nuclear translocation of β-catenin and transcription of β-catenin target genes. Hypoxia upregulates cKIT in endothelial cells, enhancing the angiogenic response to SCF. Blockade of cKIT or SCF (using cKit mutant mice and anti-SCF IgG) suppressed pathological neovascularization in murine models.\",\n      \"method\": \"Hypoxia cell culture, cKit mutant mice, anti-SCF neutralizing antibody, β-catenin chemical inhibitors, in vivo retinopathy/choroidal neovascularization models, GSK-3β and β-catenin phosphorylation assays\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic and pharmacological loss-of-function with defined signaling mechanism\",\n      \"pmids\": [\"31434494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SCF/c-Kit-activated signaling and angiogenesis require Gαi1 and Gαi3 proteins. In endothelial cells, Gαi1/3 associates with SCF-activated c-Kit, promotes c-Kit endocytosis, and facilitates binding of key adaptor proteins, thereby transducing downstream Akt-mTOR and ERK activation. Gαi1/3 silencing or KO attenuated SCF-induced HUVEC proliferation, migration, and tube formation in vitro and retinal angiogenesis in vivo. SCF/c-Kit expression was elevated in diabetic retinopathy, and SCF silencing inhibited pathological retinal angiogenesis.\",\n      \"method\": \"siRNA/shRNA knockdown, CRISPR KO, dominant-negative overexpression, endothelial-specific AAV shRNA in vivo, co-immunoprecipitation, signaling assays\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal loss-of-function approaches in vitro and in vivo with defined mechanistic pathway\",\n      \"pmids\": [\"37063428\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ENU-induced Kitl allelic series identified seven point mutations; five missense mutations affect residues within or near conserved alpha-helical domains of Kitl, establishing structural requirements for function. One allele causes a nonsense mutation with exon skipping, and one affects a splice site.\",\n      \"method\": \"ENU mutagenesis screen, sequencing of allelic series, structural mapping\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — allelic series establishing structure-function relationship in vivo\",\n      \"pmids\": [\"12242244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"PI3K p110delta is recruited to activated signaling complexes in leukocytes after treatment with stem cell factor (KITLG), together with p110alpha. Both associate with p85 adaptor subunits. Unlike p110alpha, p110delta does not phosphorylate p85 but harbors intrinsic autophosphorylation capacity, suggesting divergent regulatory capacities downstream of SCF/KIT.\",\n      \"method\": \"Immunoprecipitation, in vitro kinase assays, cytokine stimulation (SCF, IL-3, IL-4)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical recruitment assay with multiple cytokines; PI3K isoform characterization downstream of SCF/KIT\",\n      \"pmids\": [\"9113989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NRG1 and KITL (SCF) activate alternative pathways downstream of retinoic acid signaling in rat spermatogonia to support pre-meiotic spermatogonial differentiation without somatic cells. KITL prevents ERBB3-deficient spermatogonial degeneration upon differentiation. ERBB2 inhibitors blocked NRG1-dependent but not KITL-dependent spermatogonial development, demonstrating that KITL uses a distinct pathway from NRG1/ERBB2.\",\n      \"method\": \"Serum/somatic cell-free spermatogonial culture, ERBB2 pharmacological inhibitors, ERBB3-deficient spermatogonia, retinoic acid stimulation\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological and genetic dissection in defined culture system establishing distinct signaling pathway\",\n      \"pmids\": [\"26500786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"miR-27a directly targets and negatively regulates KITLG expression in Cashmere goat melanocytes. Luciferase reporter assays confirmed miR-27a binding to the KITLG 3'UTR. KITLG mRNA and protein were downregulated by miR-27a overexpression in vitro and in white goat skin (which has higher miR-27a expression), demonstrating a miR-27a → KITLG regulatory axis in pigmentation.\",\n      \"method\": \"Dual-luciferase reporter assay, miR-27a overexpression, qRT-PCR and Western blot, comparison of white vs brown skin\",\n      \"journal\": \"Animal biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct target validation by luciferase assay with in vivo correlation\",\n      \"pmids\": [\"31613171\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KITLG (KIT ligand/stem cell factor) is a transmembrane growth factor processed from two alternatively spliced isoforms (KL-1/KL-2) through regulated cell-surface proteolysis; its cytoplasmic tail contains a C-terminal valine-dependent ER export signal required for efficient cell surface delivery; it activates its receptor KIT by inducing receptor dimerization via D4-D4 lateral interactions (resolved by crystal structure), triggering downstream PI3K/Akt, ERK/MAPK, STAT5/6, and β-catenin signaling cascades that mediate survival, proliferation, migration, and angiogenesis in hematopoietic, melanocyte, germ cell, mast cell, and endothelial cell lineages; upstream, MAPK3/1 and TAK1 regulate KITLG expression to modulate these pathways, while miR-34c and miR-27a post-transcriptionally suppress KITLG; regulatory cis-elements controlling KITLG transcription (including a LEF1-responsive enhancer) drive natural variation in pigmentation across vertebrates.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KITLG (stem cell factor/SCF) is a dimeric cytokine that signals through the c-Kit receptor tyrosine kinase to regulate survival, proliferation, migration, and differentiation of melanocytes, mast cells, primordial germ cells, hematopoietic progenitors, follicular granulosa cells, osteoblasts, and endothelial cells [PMID:11764276, PMID:11861309, PMID:15917341, PMID:18448842, PMID:31434494]. Cell-surface delivery of KITLG requires a C-terminal valine ER export signal that mediates COPII-dependent ER-to-Golgi transport [PMID:15475566], and upon binding c-Kit it activates PI3K–Akt, ERK/MAPK, and GSK-3β/β-catenin pathways, with Gab2 and Gαi1/3 serving as essential signal transducers [PMID:11861309, PMID:31434494, PMID:37063428]. KITLG expression is transcriptionally regulated by HIF-1α under hypoxia and by TAK1 in keratinocytes, and post-transcriptionally by miR-34c [PMID:25799412, PMID:21233843, PMID:26674205]. Mutations in KITLG cause familial progressive hyper- and hypopigmentation and non-syndromic hearing loss with features of Waardenburg syndrome type 2 [PMID:21368769, PMID:26522471].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Analysis of Sl and W mutant mice established that spatiotemporally regulated KITLG expression through c-Kit controls distinct stages of melanocyte migration, survival, and differentiation, resolving the cellular basis of the Steel/White phenotypes.\",\n      \"evidence\": \"Genetic loss-of-function (Sl/W mutants), anti-c-Kit antibody blockade, and SCF transgene expression in mice\",\n      \"pmids\": [\"11764276\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise downstream signaling pathways in melanocytes were not resolved\", \"Whether KITLG acts as membrane-bound versus soluble form for each developmental function was not distinguished\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of Gab2 as a required adaptor downstream of KITLG/c-Kit revealed that ERK and Akt activation depend on this scaffolding protein for mast cell development, connecting ligand binding to specific intracellular cascades.\",\n      \"evidence\": \"Gab2 knockout mice with KitL stimulation, Western blot for ERK/Akt phosphorylation, mast cell enumeration\",\n      \"pmids\": [\"11861309\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of Gab2 recruitment to c-Kit not defined\", \"Whether Gab2 requirement extends to non-mast cell lineages unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"ENU-induced missense alleles mapped critical residues within or near conserved alpha-helical domains of KITLG, defining structural requirements for ligand function.\",\n      \"evidence\": \"ENU mutagenesis screen, sequencing, structural mapping of seven Kitl alleles\",\n      \"pmids\": [\"12242244\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No crystal structure or binding affinity measurements for mutant proteins\", \"Alleles not tested with purified recombinant protein in vitro\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery that a C-terminal cytoplasmic valine serves as a COPII ER export signal resolved how transmembrane KITLG reaches the cell surface, revealing a rate-limiting trafficking step.\",\n      \"evidence\": \"Mutagenesis of cytoplasmic tail, GFP-tagged KITLG live-cell imaging, COPII vesicle recruitment assay\",\n      \"pmids\": [\"15475566\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether post-ER trafficking steps impose additional regulation is unresolved\", \"Cargo receptor mediating COPII recognition not identified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"An allelic series of Kitl hypomorphic mutations demonstrated that different threshold levels of KITLG are required for primordial germ cell proliferation versus migration, establishing dose-dependent functions in germline development.\",\n      \"evidence\": \"ENU-induced Kitl allelic series in mice, PGC counting and positional analysis at multiple stages\",\n      \"pmids\": [\"15917341\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis for differential dose thresholds not determined\", \"Whether membrane-bound versus soluble KITLG differentially affects proliferation versus migration not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Exogenous KITLG rescued VCD-induced primordial/primary follicle loss in ovarian cultures, establishing a direct pro-survival role for KITLG/c-Kit signaling in follicular maintenance.\",\n      \"evidence\": \"In vivo VCD dosing and in vitro ovarian culture with exogenous KITLG, RT-PCR and Western blot\",\n      \"pmids\": [\"18448842\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream survival pathway in follicles not fully delineated\", \"In vivo rescue not performed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of KITLG mutations in conserved β-strand residues as causes of familial progressive hyper- and hypopigmentation, and demonstration that TAK1 regulates KITLG expression to protect keratinocytes from ROS-induced apoptosis, expanded the disease and transcriptional-regulatory landscape of KITLG.\",\n      \"evidence\": \"Genome-wide linkage with cosegregation (FPHH families); TAK1 KO keratinocytes with SCF rescue and pathway inhibitors\",\n      \"pmids\": [\"21368769\", \"21233843\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"FPHH mutations not functionally tested for c-Kit binding\", \"TAK1-to-KITLG transcriptional mechanism not defined at promoter level\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Multiple studies collectively established that KITLG mutations cause non-syndromic hearing loss/Waardenburg syndrome type 2 (with defined trafficking defects), that HIF-1α directly transactivates the KITLG promoter under hypoxia, that miR-34c post-transcriptionally suppresses KITLG, and that KITLG acts downstream of retinoic acid independently of ERBB2/3 to support spermatogonial differentiation.\",\n      \"evidence\": \"In vitro mutant trafficking/secretion assays; ChIP and luciferase reporter for HIF-1α binding; miR-34c overexpression/inhibition with KITLG readout; spermatogonial culture with ERBB inhibitors and exogenous KITL\",\n      \"pmids\": [\"26522471\", \"25799412\", \"26674205\", \"26500786\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether HIF-1α regulation of KITLG operates in non-cancer contexts not shown\", \"miR-34c–KITLG axis validated only in colorectal cancer cells\", \"Hearing loss mutations not tested for c-Kit activation capacity\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstration that SCF/c-Kit drives ocular neovascularization through GSK-3β phosphorylation and β-catenin nuclear translocation identified a new effector arm of KITLG signaling in angiogenesis.\",\n      \"evidence\": \"cKit mutant mice, anti-SCF neutralizing antibody, oxygen-induced retinopathy/laser CNV models, β-catenin inhibitors\",\n      \"pmids\": [\"31434494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether β-catenin arm operates in non-ocular angiogenesis not tested\", \"Direct interaction between c-Kit and GSK-3β pathway not biochemically defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of Gαi1/3 as obligate transducers that associate with activated c-Kit and promote receptor endocytosis, Akt-mTOR, and ERK signaling revealed a heterotrimeric G-protein–RTK crosstalk node essential for SCF-driven angiogenesis.\",\n      \"evidence\": \"Co-IP, siRNA/KO/dominant-negative approaches, AAV-shRNA endothelial knockdown in retinal angiogenesis model\",\n      \"pmids\": [\"37063428\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Gαi1/3–c-Kit interaction unknown\", \"Whether Gαi1/3 requirement extends to non-endothelial KITLG-responsive cells not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural determinants of membrane-bound versus soluble KITLG signaling specificity, the full set of transcription factors and miRNAs regulating KITLG in different lineages, and whether Gαi–c-Kit coupling operates broadly across KITLG-dependent cell types.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of KITLG–c-Kit signaling complex with intracellular effectors\", \"Relative contributions of membrane-bound versus soluble isoforms to each developmental function remain unresolved\", \"Comprehensive cis-regulatory map of KITLG locus lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 3, 9, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 9, 10, 13]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 4, 16]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [4, 7, 8, 16]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"KIT\",\n      \"GAB2\",\n      \"GNAI1\",\n      \"GNAI3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"KITLG (Kit ligand/stem cell factor) is a transmembrane growth factor that signals through the receptor tyrosine kinase KIT to regulate survival, proliferation, migration, and differentiation of hematopoietic stem cells, melanocytes, germ cells, mast cells, and endothelial cells [PMID:2208279, PMID:11861309, PMID:28714970]. It is produced as two alternatively spliced transmembrane isoforms (KL-1 and KL-2) that differ in susceptibility to regulated proteolytic shedding, with tissue-specific isoform ratios controlling the balance of membrane-bound versus soluble ligand [PMID:1378327]; efficient surface delivery requires a C-terminal valine-dependent ER export signal in its cytoplasmic tail [PMID:15475566]. Binding of KITLG induces KIT receptor dimerization via lateral D4–D4 and D5–D5 domain contacts, activating downstream PI3K/Akt, ERK/MAPK, STAT5/6, and GSK-3β/β-catenin cascades through adaptors including Gab2 and Gαi1/3 [PMID:17662946, PMID:11861309, PMID:15217825, PMID:31434494, PMID:37063428]. Cis-regulatory variation at the KITLG locus—including a LEF1-responsive enhancer harboring the SNP rs12821256—underlies natural pigmentation differences across vertebrates, and coding mutations in KITLG cause familial progressive hyper- and hypopigmentation [PMID:24880339, PMID:18083106, PMID:21368769].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Cloning of KITLG established it as a hematopoietic growth factor that synergizes with colony-stimulating factors to expand myeloid and lymphoid progenitors, defining its primary biological role.\",\n      \"evidence\": \"cDNA cloning from rat and human with recombinant protein expression and bone marrow progenitor proliferation assays\",\n      \"pmids\": [\"2208279\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"receptor identity (KIT) known but structural basis of interaction unresolved\", \"in vivo requirement not yet demonstrated by genetic loss-of-function of KITLG itself\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Discovery of two alternatively spliced KITLG isoforms (KL-1/KL-2) with differential proteolytic shedding efficiency revealed that the balance of membrane-bound versus soluble ligand is regulated at the level of splicing and cell-surface cleavage.\",\n      \"evidence\": \"Alternative splicing analysis, phorbol ester and calcium ionophore stimulation, Western blot of shed products\",\n      \"pmids\": [\"1378327\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"identity of the protease(s) responsible for constitutive and regulated shedding not determined\", \"functional consequence of membrane-bound vs soluble forms on KIT signaling duration not dissected\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identification of PI3K p110δ and p110α recruitment to KIT-associated complexes after SCF stimulation placed PI3K activation as a proximal signaling event downstream of KITLG/KIT.\",\n      \"evidence\": \"Immunoprecipitation and in vitro kinase assays in leukocytes stimulated with SCF\",\n      \"pmids\": [\"9113989\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"relative functional contributions of p110α vs p110δ downstream of KIT not determined\", \"recruitment mechanism (direct vs adaptor-mediated) not fully resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Gab2 was identified as a required adaptor downstream of KIT, linking KITLG signaling to ERK and PI3K/Akt activation and mast cell development, thereby defining the signal transduction architecture from receptor to effector kinases.\",\n      \"evidence\": \"Gab2 knockout mice with impaired mast cell development and reduced ERK/Akt activation upon SCF stimulation\",\n      \"pmids\": [\"11861309\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether Gab2 is required in non-mast cell lineages (e.g. melanocytes, HSCs) for KITLG signaling not tested\", \"structural basis of Gab2–KIT interaction not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"An ENU-induced allelic series of Kitl mutations mapped functional requirements to conserved α-helical domains, establishing structure–function relationships in vivo.\",\n      \"evidence\": \"ENU mutagenesis screen with sequencing and structural mapping of seven point mutations\",\n      \"pmids\": [\"12242244\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"no crystal structure of KITLG alone or in complex at this point to place mutations structurally\", \"allele severity not quantitatively correlated with receptor binding affinity\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identification of a C-terminal valine as an ER export signal for KITLG revealed that its surface delivery depends on COPII-mediated vesicular transport, establishing a trafficking control point upstream of ligand presentation.\",\n      \"evidence\": \"Mutagenesis of cytoplasmic tail valine, live-cell GFP imaging, ER accumulation phenotype\",\n      \"pmids\": [\"15475566\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"COPII coat subunit specificity for KITLG recognition not identified\", \"whether this export signal is regulated in physiological contexts unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstration that SCF/KIT activates PI3K/Akt and ERK in endothelial cells to drive survival, migration, and tube formation extended the biological scope of KITLG signaling beyond hematopoietic lineages to angiogenesis.\",\n      \"evidence\": \"Pharmacological inhibition (PI3K, MEK, c-Kit) combined with HUVEC survival, migration, and tube formation assays\",\n      \"pmids\": [\"14985355\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"relative importance of soluble vs membrane-bound KITLG for angiogenesis not addressed\", \"in vivo confirmation of endothelial-autonomous KIT requirement pending\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"SCF/KIT uniquely activates STAT5 and STAT6 in mast cells (distinct from FcεRI), revealing receptor-specific signaling that explains the non-redundant role of KITLG in mast cell biology.\",\n      \"evidence\": \"Phospho-specific Western blotting in primary human mast cells comparing SCF vs antigen stimulation\",\n      \"pmids\": [\"15217825\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"direct transcriptional targets of STAT5/6 downstream of KIT in mast cells not catalogued\", \"mechanism of synergy between SCF and antigen for degranulation not molecularly defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Graded Kitl hypomorphic alleles in mice showed that different threshold levels of KITLG are required for PGC proliferation versus migration, demonstrating quantitative dose-dependence of KITLG in germ cell development.\",\n      \"evidence\": \"Phenotypic comparison of ENU-induced Kitl allelic series at multiple developmental stages\",\n      \"pmids\": [\"15917341\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"downstream pathways mediating proliferation vs migration distinction not identified\", \"whether membrane-bound vs soluble KITLG accounts for the threshold difference untested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Crystal structures of the full KIT ectodomain in complex with SCF resolved the activation mechanism: SCF induces KIT dimerization, which enables homotypic D4–D4 and D5–D5 lateral contacts essential for kinase activation, explaining how oncogenic mutations in these interfaces constitutively activate KIT.\",\n      \"evidence\": \"X-ray crystallography of KIT ectodomain ± SCF, point mutagenesis of D4–D4 contacts with cell-based KIT activation assays\",\n      \"pmids\": [\"17662946\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"full-length KIT structural model including kinase domain not available\", \"dynamics of dimer rearrangement at the membrane not captured by crystal structure\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Cis-regulatory changes at the KITLG locus were shown to drive parallel evolution of reduced pigmentation in sticklebacks and to contribute to human skin color, establishing KITLG as a major evolutionary pigmentation gene controlled at the transcriptional level.\",\n      \"evidence\": \"Genetic crosses and expression studies in sticklebacks combined with admixture mapping in humans\",\n      \"pmids\": [\"18083106\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"specific transcription factors and enhancer elements not yet identified\", \"quantitative effect size in human pigmentation not precisely measured\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"TAK1 was placed upstream of KITLG expression in keratinocytes, linking innate signaling kinases to SCF/c-Kit/Akt-mediated protection against ROS-induced apoptosis and defining a TAK1→KITLG→KIT→Akt survival axis in skin.\",\n      \"evidence\": \"TAK1 knockdown/overexpression, exogenous SCF rescue, pharmacological KIT/Akt inhibition, organotypic skin culture\",\n      \"pmids\": [\"21233843\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanism by which TAK1 induces KITLG transcription not defined\", \"whether this axis operates in non-keratinocyte contexts untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of KITLG coding mutations in familial progressive hyper- and hypopigmentation (FPHH) established KITLG as a Mendelian pigmentation disease gene and demonstrated that specific mutations impair membrane localization or soluble ligand secretion.\",\n      \"evidence\": \"Whole-exome sequencing with linkage analysis, in vitro membrane localization and secretion assays for identified mutations\",\n      \"pmids\": [\"21368769\", \"26522471\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"dominant-negative vs haploinsufficiency mechanism for specific alleles not fully resolved\", \"effect of mutations on KIT binding affinity not measured\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"A specific SNP (rs12821256) in a KITLG enhancer was shown to reduce LEF1-dependent transcription, and transgenic mice carrying the human variant had reduced hair pigmentation, providing the molecular basis for blond hair in Europeans.\",\n      \"evidence\": \"Enhancer reporter assays, LEF1 binding site mutagenesis, transgenic mouse enhancer knock-in\",\n      \"pmids\": [\"24880339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether additional transcription factors cooperate with LEF1 at this enhancer unknown\", \"melanocyte-specific vs keratinocyte-specific enhancer activity not fully dissected\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"KITLG was validated as a direct post-transcriptional target of miR-34c and miR-27a, establishing microRNA-mediated regulation of KITLG expression in colorectal cancer and melanocyte pigmentation contexts.\",\n      \"evidence\": \"Dual-luciferase 3′UTR reporter assays confirming direct miRNA binding, miRNA overexpression/inhibition with KITLG protein readouts\",\n      \"pmids\": [\"26674205\", \"31613171\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"physiological relevance of miR-34c regulation of KITLG in normal colon epithelium not established\", \"combinatorial effects of multiple KITLG-targeting miRNAs not assessed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Conditional deletion of Scf in bone marrow adipocytes demonstrated that adipocyte-derived KITLG is required for HSC maintenance and hematopoietic regeneration after myeloablation, identifying a niche-specific source of KITLG critical for emergency hematopoiesis.\",\n      \"evidence\": \"Adipoq-Cre/ER-driven conditional Scf knockout, irradiation and 5-FU models, HSC enumeration, survival analysis\",\n      \"pmids\": [\"28714970\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether adipocyte-derived KITLG acts via soluble or membrane-bound isoform in the niche not determined\", \"relative contributions of adipocyte vs LepR+ stromal KITLG not quantitatively resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The SCF/KIT→GSK-3β→β-catenin signaling axis was identified as a driver of pathological neovascularization, and Gαi1/3 proteins were shown to be required co-transducers for KIT-mediated Akt-mTOR and ERK activation in endothelial cells, completing the proximal signaling chain from receptor to effectors.\",\n      \"evidence\": \"cKit mutant mice, anti-SCF antibody, β-catenin inhibitors in retinopathy models; Gαi1/3 CRISPR KO and co-immunoprecipitation with activated KIT in HUVECs\",\n      \"pmids\": [\"31434494\", \"37063428\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanism by which Gαi1/3 couples to a receptor tyrosine kinase (rather than GPCR) is structurally undefined\", \"whether Gαi1/3 requirement extends to non-endothelial KITLG-responsive lineages is unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The identity of the protease(s) responsible for constitutive and regulated KITLG ectodomain shedding, the structural basis for isoform-specific cleavage, and how membrane-bound versus soluble KITLG differentially activate KIT signaling duration and quality remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"sheddase identity not definitively assigned despite candidates (ADAM17/ADAM10)\", \"no quantitative model of how soluble vs membrane-bound SCF ratio tunes signal output in vivo\", \"full-length KIT–SCF complex structure including transmembrane and kinase domains unavailable\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 4, 8, 10, 19, 20, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 3, 14]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [1, 14]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 4, 5, 8, 13, 20, 21, 23]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 9, 15, 24]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 2, 19]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [13, 16]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 16, 20]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"KIT\",\n      \"GAB2\",\n      \"GNAI1\",\n      \"GNAI3\",\n      \"PIK3CD\",\n      \"LEF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}